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 ABSTRACT 
 
Quercetin and Dietary Lipids Alter the Cellular Redox Environment of the Colonocyte 
in the Promotion Stage of Colon Carcinogenesis. (August 2008) 
Kimberly Jones Paulhill, B.S., Texas A&M University 
Chair of Advisory Committee: Dr. Nancy D. Turner 
 
Quercetin (Q), a water-soluble flavonoid that is ubiquitous to foods of plant 
origin is postulated to protect against colon cancer due to its antioxidant activity. In 
contrast, we have shown that a dietary combination of fish oil (FO; n-3 fatty acids) and 
pectin may protect against colon cancer by decreasing endogenous antioxidant enzyme 
activities leading to increased reactive oxygen species (ROS), an inducer of apoptosis. 
We hypothesized that adding an antioxidant to a FO diet may negate the beneficial 
effects of FO by counteracting FO effects on colonocyte redox status. To test this, we 
provided 40 rats with FO or CO (fiber = pectin) diets with Q being 0 or 0.45% of the diet 
for 10 wk.  All rats were injected with azoxymethane (AOM) on d 21 and 28.  
Measurements included: aberrant crypt (AC) enumeration (colon cancer marker); 
apoptosis (TUNEL assay); catalase (CAT), superoxide dismutase (SOD), and 
glutathione peroxidase (GPx) activities; reduced and oxidized glutathione concentrations 
(GSH/GSSG); and oxidative DNA damage (8-OHdG adducts).  AC numbers were lower 
in FO vs CO rats (p<0.0001), but tended to increase for FO diets containing Q 
(P<0.098).  The apoptotic index was higher (p<0.0001) when Q was added to the FO and 
CO diets.  Total SOD (lipid main effect, p=0.0136) and GPX activity (p=0.0025) was 
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elevated in CO rats.  CAT activity was higher (p=0.0204) in FO rats, however Q 
diminished this effect.  GSH was not affected by diet; yet, GSSG accumulated 
(p=0.0554) in CO rats with Q as compared to CO rats without Q. The GSH/GSSG ratio 
was lower (p=0.0314) in CO rats than in FO rats.  There was no difference in 8-OHdG 
adduct levels in FO vs CO rats, however, Q decreased 8-OHdG adducts in CO rats 
(p=0.0428).  Despite increasing apoptosis, Q did not significantly lower AC formation. 
These data suggest that the distinct effects of the CO/Q and FO/Q combinations are 
functioning through different mechanisms to induce apoptosis.  The long-term 
consequences of adding antioxidants such as Q to a diet thought to exert its anticancer 
effect through a pro-oxidant mechanism are unknown and deserve further study.  
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CHAPTER I 
INTRODUCTION  
Colon cancer is one of the leading causes of cancer related deaths in the 
United States.  Colon cancer is a multi-step process progressing to an invasive 
stage over many years.  Oxidative DNA damage is one possible contributor to 
cancer or tumor formation in the intestine (1-3). Studies have revealed that a 
sustained increase over time in reactive oxygen species (ROS) correlates positively 
with an increase in oxidative DNA damage initiating malignant cells (4,5).   
Colon cancer has been shown in previous studies to be influenced by diet, 
and several studies have revealed that the level of consumption and type of dietary 
fat and fiber are two of the most significant dietary determinants for the risk of 
colorectal cancer (6-12). A diet rich in n-3 PUFAs, such as those found in fish oil, 
in combination with the fermentable fiber, pectin, is shown to be protective against 
an experimental model of colon carcinogenesis in rats at each stage of 
carcinogenesis from initiation to tumor formation (7,9,13).  In contrast the dietary 
combination of corn oil and cellulose has been shown to be promotive of tumor 
formation (7). The combination of dietary fish oil and pectin resulted in an 
increase in apoptosis (a form of programmed cell death) along with a decrease in 
the level of cellular DNA damage, which proved to be beneficial in suppressing 
tumor formation (14,15). One proposed mechanism for the effectiveness of the 
dietary combination of fish oil and pectin is an increase in ROS inducing more 
                                                   This thesis follows the style and format of The Journal of Nutrition. 
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apoptosis.  This increase in apoptosis leads to a decrease in the number of 
damaged cells (14,16-18).  Another mechanism postulated to support the 
effectiveness of a fish oil pectin diet is not only the significant increase in ROS but 
also a concomitant decrease in antioxidant enzyme capacity (9).  These changes 
occurring in colonocytes should also contribute towards a decrease in aberrant 
crypt formation (pre-neoplastic lesions), and eventual colon tumor development. 
 Other epidemiologic studies have shown that the proportion of the 
population with the lowest intake of fruits and vegetables has nearly twice the 
incidence of cancer of epithelial origin than those with the highest intake of fruits 
and vegetables (19-21).  Quercetin, a water-soluble flavonoid that is ubiquitous to 
foods of plant origin has been postulated to decrease the number of aberrant crypt 
foci (ACF) by inhibiting the growth of malignant cells through down regulation of 
cell proliferation and increasing apoptosis.  These responses have been, in part, 
attributed to quercetin’s antioxidant capacity (22-32).   
Salganik et al. (33), however, demonstrated that feeding antioxidant depleted 
diets devoid of vitamins A and E inhibited tumor growth in mice by enhancing 
apoptosis, whereas an antioxidant-rich diet (with vitamins E and A supplemented 
at twice the level of a standard diet) had relatively little effect on tumor growth.  
Thus, if quercetin is functioning as a strong antioxidant, then it is possible that the 
protective, pro-apoptotic environment that normally exist in the colon caused by 
the combination of fish oil and pectin could be compromised due to elevated levels 
of dietary antioxidants such as quercetin (34). 
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We hypothesized that the addition of an antioxidant (quercetin) to a fish oil 
and pectin diet would alter the redox status of the rat colonic epithelial 
environment, which would counteract the pro-apoptotic protective effects of fish 
oil and pectin in the promotion stage of colon carcinogenesis. The purpose of this 
study was to determine whether elevated levels of quercetin influence the redox 
status of rat colonocytes through changes in antioxidant enzyme activities and 
shifts in GSH/GSSG cellular levels.  These changes should lead to changes in 
apoptosis, oxidative DNA damage, and ACF numbers. 
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CHAPTER II 
LITERATURE REVIEW 
 
Research Justification 
 
Initiation of malignant colonocytes.  The intestinal colonic epithelium is 
organized into small invaginations called crypts that open into the lumen.  These 
crypts allow for increased surface area to enhance nutrient absorption.  A single 
layer of epithelial cells line the crypts and are responsible for the secretory, 
absorptive, and barrier functions of the large intestine. The epithelial cells maintain 
a highly-controlled balance of cell growth (proliferation) and programmed cell 
death (apoptosis), thus any perturbation of this balance may reflect a malignant 
transformation that may lead to tumorigenesis (35-39).  Cells differentiate and 
move up the crypt as they age and lose their ability to proliferate.  Eventually these 
differentiated colonocytes undergo apoptosis and/or are exfoliated into the fecal 
stream (40,41). 
Carcinogenesis in humans is a multi-step process, involving multiple genetic 
mutations that transform normal cells into a malignant phenotype. Cancer is 
typically defined in three stages: initiation, promotion, and progression, with each 
stage possessing distinct morphological characteristics.  The initiation stage of 
colon carcinogenesis is characterized by the production of DNA lesions or adducts 
that can be caused by oxidative stress generated by excess ROS. These lesions 
cause changes in DNA structure that can lead to genetic alterations such as 
mutational activation of oncogenes and the silencing of tumor suppressor genes 
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(35-39,42).   These alterations could cause cells to hyperproliferate and evade 
apoptosis (42-47), and are considered initiated or precancerous cells.  However, 
these mutations can usually be repaired during DNA synthesis.  Whenever DNA 
repair or apoptotic removal fails to eliminate mutated colonocytes, then the early 
preneoplastic lesions of colon cancer (aberrant crypts) develop, which can 
eventually lead to polyp and tumor formation. 
 
Aberrant crypts.  The promotion stage of colon carcinogenesis involves clonal 
expansion of initiated cells that accumulate more DNA damage or are 
“misrepaired” thereby gaining a selective growth advantage.  The crypts become 
larger and abnormally shaped compared to normal crypts.  An accumulation of 
cells of the malignant phenotype then results. Groupings of these abnormal crypts 
are called aberrant crypt foci (ACF).  Evidence suggests that foci incorporating 
large numbers of aberrant crypts (AC) are preneoplastic lesions of colon cancer, 
and are common biomarkers which have been identified in human colons (42,45).  
Studies reveal that colonocytes lining ACF have an increase in proliferation (48-
50) and a resistance to apoptosis (48,49,51) which provide further evidence that 
ACF are preneoplastic lesions and the ACF assay is a reliable intermediate 
biomarker that can be used to evaluate the development of colon carcinogenesis in 
experimental animal models.  Though events in the promotion stage are reversible, 
if damage continues and is not repaired correctly or transformed cells eliminated, 
accumulating cells can progress to tumors.  This suggests that the promotion stage 
of tumorigenesis is an ideal target for colon cancer prevention strategies (52,53).  
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Chemoprotective agents that decrease the proliferation of malignant cells while 
enhancing the elimination of precancerous cells through apoptosis can alter the 
progression of malignant cells and lead to a decrease in the selective growth 
advantage of putative preneoplastic lesions (29). 
 
Apoptosis.  Apoptosis is one form of cell death that can eliminate damaged cells 
with the potential to form cancerous cells. Apoptosis is initiated through signaling 
pathways that have been well characterized and are highly conserved among 
species (54).  These pathways are influenced by ROS and include disruption of the 
mitochondrial membrane, activation of caspases, and changes in gene expression.  
The loss of mitochondrial membrane potential (MMP) is the most obvious change 
that alters the mitochondria early in the apoptotic sequence.  ROS can also oxidize 
the mitochondrial membrane lipids causing damage to the lipids and thus altering 
MMP (54).  The mitochondria are more susceptible to damage by ROS when there 
is a greater content of long chain polyunsaturated fatty acids in the membrane (16).  
If severe oxidative stress occurs in the mitochondria, the permeability transition 
pores can be opened, which in addition to altering the MMP, can release large 
molecules into the cytosol such as cytochrome c and apoptotic inducing factor.  
These molecules continue the downstream events of apoptosis (55).  A cascade of 
cell-signaling and caspase-mediated events that regulate pro- and anti-apoptotic 
proteins such as the Bcl-2 family members then results (56).  In response to 
appropriate signals, these proteins can be modified post-translationally by kinases 
(44,55,57).  ROS have been shown to play a critical role as a second messenger in 
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cell signaling (58) and as an inducer of apoptosis. Furthermore an increase in ROS 
leading to apoptosis has been suggested to suppress tumorigenesis (9).   
 
Reactive oxygen species.  Reactive oxygen species (ROS) are a group of transient, 
highly active molecules (some of which contain an oxygen radical) that can be 
generated by both exogenous and endogenous sources such as those derived as a 
byproduct of normal cellular metabolism (36,59).  ROS include superoxide (O2-.), 
hydrogen peroxide (H2O2), and the hydroxyl radical (.OH) (2,4,5,60).  Likely 
endogenous origins of ROS include oxidative phosphorylation, p450 metabolism, 
peroxisomes, and inflammatory cell activation. 
The production of ATP through electron transport reactions in which O2 
accepts electrons and H+ and is reduced to water is the basis of cellular 
metabolism.  However, leakage of a single electron being transferred can occur 
resulting in O2- production. During mitochondrial oxidative metabolism, most 
oxygen consumed is reduced to water; however on average 1 to 5% of molecular 
oxygen is converted to ROS, essentially superoxide anion, making mitochondria a 
major site of ROS production (36-38,61).  The endoplasmic reticulum is another 
site of electron transport.  Here the leakage of electrons from NADPH cytochrome 
p450 reductase also generates O2- (61). 
Under normal physiological conditions excess ROS formation is prevented 
by the cell’s endogenous antioxidant defense systems. However, in highly 
oxidative environments, oxidative stress can occur.  Oxidative stress is an 
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imbalance of oxidants verses antioxidants in favor of the oxidants.  This results in 
an overall increase of cellular levels of ROS (36).    
 
Antioxidant enzyme capacity.  The precise modulation of ROS levels are needed 
to allow for normal cellular function or to induce apoptosis of precancerous or 
transformed cells. ROS levels can exceed the antioxidant capabilities of the cell’s 
antioxidant defense systems, which include removal of ROS by superoxide 
dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) enzymes as 
well as non-enzymatic redox compounds such as glutathione, thioredoxin, 
glutaredoxins, nicotinamide adenine dinucleotide phosphate (NADP), and 
exogenously absorbed micronutrients and vitamins (36,38,39,62,63).  There is a 
balance that is essential for the survival and health of an organism between both 
the activities and the intracellular level of these antioxidants (38). 
The enzymes work together as an antioxidant defense system such that when 
superoxide anion (O2-.) appears in the environment, the anion is scavenged by 
SOD and produces H2O2 and water.  From this point GPx decomposes H2O2 and 
reduced glutathione (GSH) is oxidized (GSSG).  CAT competes with GPx to 
decompose excess H2O2 to water and molecular oxygen (64).    
There are three isoforms of SOD in humans, cytosolic (Cu/Zn-SOD), 
mitochondrial (Mn-SOD), and extracellular SOD (EC-SOD).  Cu/Zn-SOD is a 
homodimer with a molecular weight of about 32 kDa that specifically catalyzes the 
dismutation of the superoxide anion to oxygen and water.  Each subunit contains a 
dinuclear metal cluster of copper and zinc as the active site.  Mitochondrial Mn-
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SOD is a tetramer containing one manganese molecule per subunit.  The 
respiratory chain in the mitochondria is a major source of oxygen radicals and Mn-
SOD is one of the most effective antioxidant enzymes and has been postulated to 
have anti-tumor activity (65).  EC-SOD is a tetrameric, copper and zinc 
containing, secretory glycoprotein, and is regulated more by cytokines rather than 
by responses of individual cells to oxidants (39). 
  CAT is found in peroxisomes, which are organelles in the cells of plants, 
animals, and aerobic bacteria.  CAT protects the cell from hydrogen peroxide 
produced within the cell, and water and molecular oxygen are formed when CAT 
efficiently reacts with H2O2.  Although CAT plays an important role in the 
acquisition of tolerance to oxidative stress in the adaptive response, CAT is not 
essential for some cell type under normal physiologic conditions (65). 
GPx, a selenium containing peroxidase, catalyzes the reduction of 
hydroperoxides at the expense of GSH and therefore protects the cell against 
oxidative damage.  GPx has five isoenzymes expressed ubiquitously in mammals 
and their antioxidant properties allow them to eliminate peroxides as possible 
substrates for the Fenton reaction.  GPx enzymes add two electrons to reduce 
hydrogen peroxide to water while oxidizing GSH at the same time. Although GPx 
shares hydrogen peroxide as a substrate with CAT, GPx can react effectively alone 
with lipid and other organic peroxides, and is the major source of protection 
against low levels of oxidant stress. 
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Reduced and oxidized glutathione.  The tripeptide, glutathione (GSH) is 
multifunctional and highly abundant in the cytosol, nucleus, and mitochondria of 
the cell, as well as the major thiol, nonenzymatic soluble antioxidant in these same 
cell compartments (38).  GSH has many protective roles against oxidative stress 
such as detoxifying hydrogen and lipid peroxides by catalytic action of GPx, 
scavenging of hydroxyl radical and singlet oxygen, regeneration of important 
antioxidants to their active form, and acting as a cofactor of several detoxifying 
enzymes.  Oxidized glutathione (GSSG) is a disulphide.  The redox state of critical 
protein sulphydryls necessary for DNA repair and expression are maintained in the 
nucleus by GSH (38,39).  Because GSSG is accumulated in the cell, the ratio of 
GSH/GSSG is a good measure of oxidative stress in the organism as well as the 
capacity of glutathione to regenerate the most important antioxidants (66,67).  
Many enzymes can be oxidatively damaged at higher than normal levels of GSSG.  
ROS are therefore critical determinants of cellular redox status, which is in part 
determined by the proportional amount of reduced and oxidized forms of the GSH 
redox system pair, and thus constitute a regulatory mechanism in the cell through 
the modification of protein conformation and functional signal transduction 
(38,39).  Several studies suggest that an oxidative shift in the cellular environment 
is critical to generating the apoptotic signal, not ROS alone (68-71).  Therefore 
changes in the ratio of GSH/GSSG can determine modulations in the cellular 
redox environment.  In fact, Wang et al. (70) detected significant changes in 
GSH/GSSG within 15 min of an oxidative challenge, which correlated with later 
caspase activation.  Esteve et al. (69) observed that GSH oxidation preceded DNA 
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fragmentation, a characteristic of apoptosis.  Therefore, measurement of changes 
in the oxidative environment using the GSH redox cycle may provide better 
insights into the mechanisms of ROS-mediated apoptosis than just the 
measurement of ROS alone. 
 
Oxidative DNA damage.  DNA can suffer different types of damage from base 
modification by oxidation or alkylation, to single or double strand breaks. During 
gene expression and DNA replication, base modifications can lead to mismatches 
and if left un-repaired can lead to mutations.  Oxidative DNA damage is produced 
by oxidative stress generated from ROS and is one possible initiator of 
tumorigenesis (19).  DNA and other macromolecules can be attacked by ROS, 
resulting in oxidative adducts that can then lead to mutations, which can cause 
transformation of cells and subsequent tumor formation (2,5).  ROS can contribute 
to each stage of carcinogenesis.  During this initial stage of carcinogenesis, 
sustained DNA mutations are often the genetic alterations responsible for the 
hyper-proliferation and resistance to apoptosis seen in later stages of colon 
carcinogenesis (36,38,39,63).   
The oxidative DNA adduct 8-hydroxy-deoxyguanosine (8-OHdG) is 
commonly used as a biomarker for oxidative damage.  8-OHdG is one of the most 
abundant and highly mutagenic forms of oxidative DNA damage (3,72), and has 
been implicated in the tumorigenic process (73).  This lesion can induce GC → TA 
transversions during DNA replication, which are found in mutated oncogenes and 
tumor suppressor genes, if not repaired and/or removed by apoptosis (74).  The 
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proliferation of these altered cells can lead to the malignant transformation of 
colonic mucosa. 
 
Fish oil and pectin.  Extensive research has been conducted to evaluate the role of 
dietary fiber in colon cancer with ambiguous results.  The fermentable fiber pectin 
has been shown to have chemoprotective effects (16).  Butyrate a fermentation by-
product of pectin is preferentially used by colonocytes as an energy source.  
Butyrate has been found to be an inducer of apoptosis, specifically in transformed 
cells (75), and in vitro as well as in vivo studies have found butyrate to be 
antiproliferative and pro-apoptotic (11,40,76). The mechanism by which butyrate 
induces apoptosis has yet to be elucidated.  Chapkin et al. (40) suggest that 
butyrate acts through induction of a Fas death receptor pathway (extrinsic) and 
Ruemmele et al. (76) also suggest that butyrate induces apoptosis via a 
mitochondria-mediated pathway (intrinsic).  Yet, another in vitro study proposes 
that butyrate-induced apoptosis is activated through either intrinsic or extrinsic 
pathways in varying types of colon cancers (77).  In vitro and in vivo studies have 
shown that butyrate uptake by colonocytes results in enhanced mitochondrial 
function and increased ROS production (16,78).  However, evidence appears to 
support the fact that the protective role of fiber depends on type of fiber 
(fermentable or unfermentable), type of fat present in the diet, and the stage of 
tumorigenesis of the colonocyte (79).  In fact a recent study by Kolar et al. (8) 
substantiates that the combination of fish oil and pectin work coordinately to 
protect against colon tumorigenesis.  This protective effect is proposed to be in 
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part due to increasing apoptosis rather than decreasing proliferation (7,15,49).  In 
the rat experimental model of colon cancer a diet enriched with fish oil and pectin 
as the fiber source has been shown to be protective against colon cancer by 
increasing apoptosis, and decreasing proliferation, and decreasing ACF formation 
(13,16,44,80).   
 
Antioxidant properties of quercetin.  Epidemiologic studies have shown that the 
proportion of the population with the lowest level of fruit and vegetable intake has 
nearly two times the incidence of cancer of epithelial origin than those with the 
highest level of fruit and vegetable intake (19-21). Quercetin, a water-soluble 
flavonoid ubiquitous to foods of plant origin is found in at least 80% of higher 
order plants making it the most commonly ingested compound of the flavonol 
subclass of flavonoids (81).   Quercetin has been shown to inhibit the growth of 
malignant cells by down regulation of cell proliferation and an increase in 
apoptosis in a variety of experimental models, including azoxymethane-induced 
colorectal carcinogenesis in F344 rats, in CF1 mice, and in many cell culture lines 
(26,28-30,82,83). Because these responses have been, in part, attributed to 
quercetin’s antioxidant capacity (22-31), the question has been raised as to 
whether or not a pro-oxidative or anti-oxidative cellular redox environment is 
preferred in apoptosis induction of malignant colonocytes.  Salganik et al. (33) 
demonstrated that tumor growth is inhibited in mice fed an antioxidant-depleted 
diet (devoid of vitamins E and A) due to ROS-enhanced apoptosis, whereas an 
antioxidant-rich diet (vitamins E and A doubled as compared to standard diet) had 
 
 
 
 
14
 
relatively no impact on tumor growth.  Thus, if quercetin is only functioning via an 
antioxidant pathway, then it is possible that the protective, pro-apoptotic 
environment found in the colon of rats caused by the combination of fish oil and 
pectin may be negated by elevated levels of dietary antioxidants such as quercetin.  
 
Antioxidant supplementation.  Because the human diet is a complex mixture of 
oxidants and antioxidants, and the gastrointestinal tract is thought to be a major 
site of antioxidant action, the question of whether antioxidant supplementation 
might protect against cancer has been a subject of debate (84).  Salganik et al. (33) 
demonstrated that feeding antioxidant depleted diets devoid of vitamins A and E 
inhibited tumor growth in mice by enhancing apoptosis, whereas an antioxidant-
rich diet (with vitamins E and A supplemented at twice the level of a standard diet) 
had relatively little effect on tumor growth.  Results of randomized trials with one 
or more selected antioxidants supplemented to the diet and reviewing the possible 
preventative effects on disease states have been contradictory (84).  Thus far 
convincing evidence has not been found that antioxidant supplementation can 
prevent gastrointestinal cancers; but to the contrary may increase mortality 
(84,85).  Increased mortality also seems to be the case in trials using beta carotene, 
vitamin A, and vitamin E treatments for different disease states such as 
gastrointestinal cancer (84) and lung cancer (86), although the potential roles for 
vitamin C and selenium need further study (85). 
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Purpose of study.  This study evaluated the effect of the addition of an antioxidant 
(quercetin) to fish oil and pectin enriched diets on AOM exposed rat colonocytes.  
This study also determined whether quercetin influenced the cellular redox 
environment through changes in antioxidant enzyme activities, and thus apoptosis 
caused by diets containing fish oil and pectin.   
 
Hypothesis.  Addition of the antioxidant quercetin to a fish oil pectin diet will alter 
the redox status of rat colonocytes, thus possibly inhibiting the beneficial effects 
that a fish oil/pectin diet has on the induction of colonocyte apoptosis, antioxidant 
enzyme activities, and oxidative DNA damage. 
 
Specific aims.  The objectives of this study are to:   
1. Determine if quercetin has an effect on ACF formation in rats consuming a 
fish oil and pectin or corn oil and pectin diet. 
2. Determine if rat colonocyte apoptosis induction is altered by the addition of 
quercetin to fish oil and pectin or corn oil and pectin diets.  
3. Determine if quercetin alone or in combination with fish oil and pectin or 
corn oil and pectin diets change SOD, CAT, and GPx activity and therefore 
cellular redox status (reduced/oxidized glutathione levels and ratios).  
4. And lastly determine if the net effect of these changes lead to a difference in 
the amount of oxidative DNA damage. 
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CHAPTER III 
DIETARY LIPIDS AND QUERCETIN SUPPRESS COLON 
CARCINOGENESIS THROUGH DIFFERENTIAL EFFECTS ON 
APOPTOSIS AND COLONOCYTE REDOX BALANCE 
 
Introduction 
 
 The “antioxidant hypothesis” of disease prevention emerged during the 1980s 
from studies showing that people whose diets where rich in fruits and vegetables 
had a lower incidence of diabetes, stroke, heart disease, dementia, and certain 
types of cancer.  These diseases are all associated with free radical damage (87).  
Since fruits and vegetables are rich sources of antioxidants and thus have the 
power to quench free radicals by donating electrons, scientists assumed that taking 
antioxidants as supplements or fortifying foods with antioxidants should decrease 
oxidative damage and diminish disease.  And thus the hypothesis that dietary 
antioxidants are protective against disease caused by oxidative damage was born. 
Our laboratory has shown in previous studies that the combination of fish 
oil (high in n-3 fatty acids) and pectin (a butyrate producing fermentable fiber) is 
protective against colorectal cancer.  Chang et al. (7) demonstrated that a fish oil 
pectin diet reduced the incidence of tumorigenesis by increasing colonocyte 
apoptosis in the experimentally induced rat model of colon carcinogenesis. Hong 
et al. (16) suggested that the increase of apoptosis in the colonocytes of these fish 
oil and pectin enriched diet fed rats may be due in part to fish oil priming the 
colonocytes for butyrate induced apoptosis.  Because fish oil enhances the 
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unsaturation of mitochondrial phospholipids, an increase in cellular reactive 
oxygen species (ROS) levels likely occurs.  Mitochondrial function becomes 
impaired whenever the membrane is no longer able to maintain the required 
potential, which occurs in fish oil pectin rats.  Loss of mitochondrial membrane 
potential leads to the initiation of the apoptotic cascade (37,38,65,88).   
Sanders et al. (9) went on to demonstrate in rats not injected with a colon 
specific carcinogen, that ROS levels in the colonocytes of rats consuming  a 
combination of fish oil and pectin was indeed greater (p< 0.02) than ROS levels of 
rats consuming corn oil and cellulose. This increased level of ROS was inversely 
related to oxidative DNA damage. An exponential increase of the apoptotic index, 
as well as a concomitant decrease in the enzyme activity levels of superoxide 
dismutase and catalase also resulted in the fish oil and pectin fed rats.  Conversely, 
rats consuming the corn oil cellulose diet did not exhibit these relationships.   
From the results of these aforementioned studies we can infer that a fish oil 
pectin diet protects against colorectal cancer by generating a permissive 
environment such that colonocytes are more receptive to pro-apoptotic signals, 
especially those generated by ROS.  Thus, the elimination of pre-cancerous cells 
would be more likely in rats consuming diets enriched in fish oil and pectin. 
Our experimental results suggesting that a certain degree of pro-oxidant 
environment may be protective are being reflected by human studies showing that 
antioxidant supplementation may in fact be counterproductive.  Randomized 
clinical trials using antioxidants to prevent several diseases have shown that 
antioxidant supplementation can increase cancer incidence and mortality 
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(84,85,89).  Since adding significant amounts of antioxidants to the diet should 
lower cellular ROS, the ROS-dependent pathways of apoptosis induction could be 
depressed allowing more potentially cancerous cells to spread and increase tumor 
growth.  We hypothesize that adding an antioxidant to a pro-oxidant diet (fish oil 
and pectin) could negate the chemoprotective effect of the pro-oxidant diet (fish 
oil and pectin) counteracting the effects on colonocyte redox balance.   
Quercetin, a water-soluble flavonoid ubiquitous to foods of plant origin 
was our antioxidant of choice.  Quercetin is found in at least 80% of higher order 
plants making it the most commonly ingested compound of the flavonol subclass 
of flavonoids (81).  Dietary quercetin is postulated to contribute to the 
chemoprotective activities of fruits and vegetables through its antioxidant 
properties (22,23,25,26,28-31,90).  The purpose of our study was to determine if 
the addition of quercetin to an experimental diet of fish oil and pectin would 
decrease apoptosis due to modifications in cellular redox status, thus increasing 
aberrant crypt formation. 
 
Materials and Methods  
 
Experimental design.  Animal protocols used in this study were approved by the 
University Animal Care Committee of Texas A&M University, and conform to 
the National Institutes of Health guidelines. Forty male weanling (21-d old) 
Sprague-Dawley rats (Harlan Sprague Dawley, Houston, Texas), were separately 
housed in raised wire cages to reduce coprophagy and access to bedding.  The rats 
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were maintained in a temperature (18-26° C) and humidity controlled animal 
facility with a 12 h daily light/dark cycle.   
The rats were stratified by initial weight and randomized to one of four 
experimental diets (10 rats/diet), which were consumed for 70 d after an initial 5-
d acclimation period.  This study employed a 2x2 factorial design with two levels 
of quercetin (0% quercetin  or 0.45% quercetin) and two types of oil (fish oil and 
corn oil). Experimental diets and water were freely available.  All animals were 
injected with azoxymethane (AOM; 15 mg/kg body weight, Midwest Research 
Institute, Kansas City, Missouri), a colon specific carcinogen, 3 wk after starting 
the experimental diets.  A second injection was administered 1 wk later. Food 
intake (48 h) and body weight were recorded for each animal on days 18, 56, and 
67 after starting the experimental diet.  Termination occurred on day 70 for each 
animal. 
 
Experimental diets. Rats were provided with fresh diet in clean bowels daily.  
Each experimental diet contained pectin (6 g/100 g) as the fiber source, and either 
fish oil, rich in n-3 fatty acids, or corn oil, rich in n-6 fatty acids, as a lipid source 
(15 g/100 g) with or without quercetin.  Experimental diets containing fish oil 
were fortified with 3.5 g of corn oil/100 g diet to provide essential fatty acids.  
Antioxidants were also added to each experimental diet to assure equivalent 
levels in the lipid component of the diet (Table 1). 
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      TABLE 1  Composition of Experimental Diets 
 
Ingredients g/100g g/100g 
Dextrose 
Monohydrate1 
51.06 50.61 
Casein1 22.35 22.35 
DL-Methionine1 0.34 0.34 
Pectin1 6.00 6.00 
Corn Oil3 15.00 15.00 
Or Fish Oil4/Corn 
Oil3 
11.50/3.50 11.50/3.50 
Mineral Mix AIN-
76A1 
3.91 3.91 
Vitamin Mix AIN-
76A1 
1.12 1.12 
Choline Bitartrate1 0.22 0.22 
Quercetin Dihydrate2 0.00 0.45 
1Harlan Teklad, Madison, WI. 
2Sigma, St. Louis, MO. 
3Dyets, Bethlehem, PA. 
4Degussa BioActive, Champaign, IL. 
 
 
Tissue sample collection.  Following termination by CO2 asphyxiation and 
cervical dislocation, the colon was removed, cut longitudinally to expose the 
lumen, and washed in 1% PBS.  Two centimeters of the most distal colon was 
fixed in 4% PFA (1 cm) and 70% ethanol (1 cm).  The remaining section of the 
colon was divided in half. One half was used for aberrant crypt foci enumeration, 
and the other half was scraped with a glass slide to remove the mucosal layer 
which was used for antioxidant enzyme activity and glutathione analyses. 
 
Aberrant crypt foci.  Aberrant crypt foci number and multiplicity were 
determined on one half of the colon using the procedure of Vanamala et al. (91).  
The tissue was protected using RNAse free filter paper at the time of termination 
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and fixed in 70% ethanol for 24 h.  Each colon section was then stained with 
0.5% methylene blue and examined microscopically (40x).  The mucosal surface 
was used to quantify the total number of aberrant crypts and high multiplicity 
aberrant crypt foci (four or more aberrant crypts per focus). 
 
Apoptosis.  Non-serial sections cut from 1 cm of the most distal colon, fixed in 
4% paraformaldehyde (PFA) and embedded in paraffin were utilized for in situ 
measurement of apoptosis using ApopTag (Chemicon, Temecula, CA) technology 
as previously described by Chang et al. (35).  Cells stained by diaminobenzidine 
tetrachloride (DAB) and having the appropriate morphological criteria were 
scored as apoptotic and the apoptotic index determined.  The apoptotic index for 
each crypt column was determined by dividing the number of apoptotic cells in a 
crypt column by the number of cells in the crypt column. The mean apoptotic 
index of 50 crypt columns was used as the apoptotic index for each rat. 
 
Antioxidant enzyme assays.   Cell lysates were prepared by homogenization of 
scraped mucosal cells in a potassium phosphate buffer as described in Appendix 
A, followed by centrifugation for 30 min at 15,000 x g (4°C) and aliquots were 
stored at -80°C.  The supernatant was used for enzyme assays and protocols from 
the kits were followed. Total superoxide dismutase (SOD) as well as manganese 
superoxide dismutase (Mn-SOD/mitochondrial) activity was determined by 
measuring the rate of chromophore generation at 450 nm (Cayman Chemicals, 
Ann Arbor, MI) (92).  The Mn-SOD levels were determined by adding potassium 
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cyanide to inhibit copper/zinc SOD activity (65).  Catalase (CAT) activity was 
determined by measuring formaldehyde generation at 540 nm (Calbiochem, San 
Diego, CA) (93).  Glutathione peroxidase (GPx) activity was determined by 
measuring the oxidation of NADPH to NADP+ at 340 nm (Cayman Chemicals, 
Ann Arbor, MI) (94).  Samples were analyzed in triplicate in 96 well microplates, 
and measurements made using a Spectra Max 250 microtiter plate reader with 
SoftMax Pro, v.1.2 software (Molecular Devices, Sunnyvale, CA) for all assays.  
Enzyme activity was normalized to protein concentration as determined by 
Commassie Blue assay (Pierce Biotechnologies, Rockford, IL). 
 
In vivo measurement of oxidative DNA damage.  Tissue samples fixed in 70% 
ethanol and embedded in paraffin were used for in situ measurement of 8-OHdG 
adducts using a mouse monoclonal antibody for 8-OHdG (Oxis, Portland, 
Oregon, see Appendix A) and a protocol adapted from Hong et al. (16).  Tissue 
sections were deparaffinized, rehydrated, treated with RNase (100 µg/ml) in Tris 
buffer (pH 7.5, 10 mM Trizma base, 1 mM EDTA, 0.4 M NaCl), and incubated in 
humidified chamber at 37˚C for 1 h.  DNA was then denatured in 4N HCl for 7 
min and neutralized with 50 mM Trizma base for 5 min.  Tissue sections were 
incubated with 10% normal rabbit serum (Jackson, West Grove, PA) to block 
non-specific background staining followed by an overnight incubation in primary 
antibody (1:40 dilution) at 4˚C.  Tissue sections were then incubated with 
biotinylated rabbit anti-mouse IgG (1:800 dilution, Jackson, West Grove, PA) as a 
secondary antibody followed by incubation in 3% H2O2/methanol to quench 
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endogenous peroxidase. Slides were then incubated using an ABC kit (Vector 
Laboratories, Inc., Burlingame, CA), and the entire complex was visualized with 
DAB.  Omission of primary antibody was used as a negative control and 6% DSS 
treated rat colonic tissue sections were used as a positive control. Intensity of 
staining in each cell within a crypt column was measured using NIH Image 
software.  The mean stain intensity minus the average of background staining was 
determined for each nucleus in a crypt column, and 20 crypt columns per rat were 
analyzed. 
 
Determination of GSH/GSSG.   Colonic GSH and GSSG were measured using 
an HPLC method of Jones et al. (66,67) with modifications.  Snap frozen mucosal 
tissue (~50 mg) was homogenized in 0.5 ml Solution A  (1.05% L-serine, 0.1 mM 
sodium heparin, 2 mM bathophenanthroline disulfonate sodium salt, 11 mM 
iodoacetic acid, 80 mM boric acid, and 20 mM sodium tetraborate) plus 0.5 ml 
Solution B (1.2 mM perchloric acid and 200 mM boric acid).   The homogenizer 
was rinsed with 0.1 ml Solution A and 0.1 ml Solution B.  The combined 
homogenates were centrifuged at 10,000 g for 1 min.  The supernatant (150 μl) or 
150 μl of GSH and GSSG standards (0, 50, 200, and 500 μM each) were mixed 
with 30 μl of 40 mM iodoacetic acid and 100 μl of 1 M KOH/1.6 M potassium 
tetraborate (pH ~9.0), followed by addition of 150 μl of 75 mM dansyl chloride.  
The solutions were vortexed and kept in the dark at room temperature for 16 h, 
followed by addition of 250 μl chloroform.  The mixture was centrifuged at 
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10,000 g for 1 min, and 100 μl of the supernatant fluid (dansyl derivatives) was 
transferred to a micro-insert tube in a brown vial, with 25 μl injected into a 3-
aminopropyl column (5 µm; 4.6 x 250 mm; Custom LC, Houston, TX).   GSH 
and GSSG were eluted from the column using Solvent A (0.8 M sodium acetate, 
27% glacial acetic acid, and 63% methanol; pH 4.6) and Solvent B (80% 
Methanol) at the combined flow rate of 1.0 ml/min and the following gradient (0-
10 min, 20% Solvent A; 30-33 min, 80% Solvent A; 33.1-38 min, 20% Solvent 
A).  Fluorescence detection (Waters 2475 Multi-λ Fluorescence Detector) was set 
at 590 nm excitation and 610 nm emission (0.0 to 7.5 min) to eliminate the 
appearance of amino acid peaks and at 335 nm excitation and 610 nm emission 
(7.5 to 38 min) for GSH and GSSG detection.  Detector gain was set at 100 (0 to 
32.2 min) for GSH detection and at 1000 (32.2 to 38 min) for GSSG detection.  
GSH and GSSG were quantified on the basis of authentic standards (Sigma 
Chemicals, St. Louis, MO) using the MillenniumTM-32 Software and workstation.  
Data was expressed relative to protein concentration as determined by 
Coommassie Blue assay (Pierce Biotechnology, Rockford, IL). 
 
Statistical analysis.  Analysis of data acquired by the TUNEL, enzymatic activity 
assays, glutathione concentration and ratio, as well as 8-OHdG DNA adduct 
quantification were performed by mixed model analysis of variance (ANOVA) 
using SAS 9.1 (SAS Institute, Inc.).  Differences among the treatments were 
considered significant at p<0.05. Sample outliers were removed if normalization 
of the sample set did not correct for skewedness. Analysis of data acquired by the 
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aberrant crypt foci assay was measured using the nonparametric Wilcoxon Ranks 
Sums test.  
 
Results 
 
Food intake and body weight gain.  Because of the potential for differences in 
weight gain to affect the outcome, food intake (48 h) and body weight gain were 
recorded and analyzed for each animal on days 18, 56, and 67 after starting the 
experimental diets.  There were no significant differences in food intake or body 
weight gain among the experimental groups at the time of termination (see 
Appendix B). 
 
Apoptosis.  Inhibition of programmed cell death or apoptosis plays a pivotal role in 
tumorigenesis.  Therefore non-serial sections cut from 1 cm of the most distal 
colon, fixed in 4% PFA and embedded in paraffin were utilized for in situ 
measurement of apoptosis using the TUNEL assay.  There was no significant 
difference in the apoptotic index between the fish oil and corn oil animals (Fig. 1).  
However, rats whose diets were supplemented with quercetin showed a significant 
increase in the apoptotic index (p=0.0001).  
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Antioxidant enzyme activity.  When pro-oxidants such as ROS exceed antioxidant 
capabilities, oxidative stress exists.  This oxidatively stressed environment can 
result from increased generation of ROS as well as impaired removal of ROS by 
antioxidant defense systems such as SOD, CAT, and GPx enzymes.  To test for 
any variations in antioxidant capacity among the experimental diet groups SOD, 
CAT, and GPx activities were measured. We observed a consistent numerical 
reduction in the activity of total superoxide dismutase in fish oil fed animals as 
compared to corn oil fed animals when the main effect of lipid was analyzed (Fig. 
2, p=0.0136).  However, there was no difference observed in mitochondrial SOD 
activity among the diet groups (see Appendix B).  Furthermore, CAT activity was 
elevated (p=0.0119) in fish oil fed rats without quercetin supplementation (Fig. 3).  
Because these enzymes work sequentially the ratio of SOD/CAT was analyzed.  
 a 
  a 
 
  b 
  b 
FIGURE 1 Rats fed a corn oil or fish oil diet supplemented with 
quercetin displayed a greater apoptotic index as compared to rats fed 
corn oil or fish oil without quercetin supplementation. Data are means 
± SEM from 50 crypts for n=10 rats/diet.  The apoptotic index 
represents the total number of apoptotic cells in a crypt column/total 
number of cells in the crypt column. Bars not sharing a letter differ, 
p=0.0001. 
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SOD/CAT was higher in corn oil fed rats in comparison to fish oil fed rats (Fig. 4).  
GPx activity was higher in corn oil rats (Fig. 5). 
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 a  a  
b 
  b 
FIGURE 3 Rats fed a corn oil diet (n=20) had lower levels of CAT activity as 
compared to rats fed a fish oil diet (n=20, p=0.0204).  There was a significant 
difference in CAT activity between corn oil  and fish oil fed rats not 
supplemented with quercetin (n=10 rats/diet, p=0.0119), however when 
quercetin was added to the diet the difference in CAT activity was no longer 
observed.  Data are means ± SEM for n=10 rats/diet.    
   a a 
  a 
  b 
FIGURE 2 Rats fed a corn oil diet (n=20) had higher levels of SOD activity 
as compared to rats fed a fish oil diet (n=20, p=0.0136).  Data are means ± 
SEM for n=10 rats/diet.   
 
 
 
 
28
 
0
0.5
1
1.5
2
(-)Quercetin (+) Quercetin
SO
D
/C
A
T 
R
at
io
Corn Oil
Fish Oil
 
 
 
 
 
0
20
40
60
80
100
(-)
Quercetin
(+)
QuercetinG
lu
ta
th
io
ne
 P
er
ox
id
as
e 
A
ct
iv
ity
 
(U
/m
g 
pr
ot
ei
n)
Corn Oil
Fish Oil
 
 
 
 
 
Glutathione.  To have a representative indicator for the redox environment of the 
rat colonocyte, the major cellular redox buffer glutathione (GSH/GSSG) was 
measured.  There was no effect of diet or quercetin supplementation on total 
FIGURE 4 AOM injected rats fed a corn oil diet had a higher 
SOD/CAT ratio (n=18 rats/diet, p=0.0006) as compared to fish oil fed 
rats (n=19 rats).  There was a significant difference in SOD/CAT ratio 
in corn oil vs. fish oil fed rats when the diet did not contain quercetin 
(p=0.0003). Upon the addition of quercetin to the diet, the difference 
between the ratios was diminished. Data are means ± SEM for n=10 
rats for corn oil and fish oil diets, n=8 rats/ Corn oil + Quercetin, n=9 
rats/fish oil + Quercetin.   
    a   
  a 
     b 
   a,b 
  a,c 
 a,b 
 c 
  b 
FIGURE 5 Rats fed a corn oil diet (n=20) had higher levels of GPx 
activity as compared to rats fed a fish oil diet (n=20, p=0.0025).  Although 
there were numerical differences between the corn oil and fish oil fed rats 
with and without quercetin supplementation, the greatest difference in GPx 
activity was observed between corn oil and fish oil fed rats with quercetin 
supplementation (n=10 rats/diet, p=0.0136).  Data are means ± SEM for 
n=10 rats/diet.   
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glutathione or GSH concentrations (Table 2).  However, the level of GSSG was 
increased in corn oil fed rats consuming quercetin as compared to fish oil fed rats 
also consuming quercetin (p=0.0554).  The ratio of GSH/GSSG was lower in corn 
oil rats as compared to fish oil rats (p= 0.0314) with the greatest difference among 
the corn oil and fish oil rats occurring with quercetin supplementation, suggesting 
a more oxidized environment among corn oil rats especially with quercetin 
supplementation (Fig. 6). 
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Diet                                  Non Quercetin                              Quercetin                           
                                   Corn Oil       Fish Oil              Corn Oil        Fish Oil        P-values  
                                            (nmol/mg protein)                        (nmol/mg protein) 
Total Glutathione    12.41 ±  2.04      13.34 ±  2.04       10.73 ±  2.15*       14.67 ± 2.04       NS 
GSH                        11.60 ±  1.99       12.76 ±  1.99         9.61 ±  2.10*      14.19 ± 1.99       NS 
GSSG                         0.28 ±  0.10*,ab   0.27 ±   0.09ab      0.57 ± 0.20b         0.26 ± 0.09a  0.05542 
 
TABLE 2 
Total, reduced, and oxidized glutathione. Concentrations in mucosa of AOM injected 
rats fed corn oil or fish oil lipid based diets with or without quercetin supplementation 
for a total of 7wk after AOM injection1 
1Values are mean ± SEM, n=10 rats/diet 
2 p-value is for corn vs. fish with quercetin supplementation 
*outlier removed n= 9 rats 
FIGURE 6  AOM injected rats fed a corn oil diet (n=20) had a lower 
GSH/GSSG ratio in colonic mucosal scrapings suggesting a more 
oxidized environment in corn oil fed rats as compared to fish fed rats. 
Quercetin supplementation had little effect on GSH/GSSG.  Data are 
means ± SEM for n=10 rats/diet.  Bars not sharing a letter differ, 
p=0.0314. 
    
a 
b 
  b 
       a 
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Oxidative DNA damage.  Because damage to DNA is one consequence of 
excessive oxidative stress, and several oxidative adducts including 8-oxodG have 
been implicated in the tumorigenic process, 8-OHdG adduct formation in the distal 
colon was measured in situ.  There was no difference in overall levels of oxidative 
DNA damage as determined by 8-OHdG adduct quantification in fish oil vs corn 
oil fed rats.  However, upon the addition of quercetin to the diet, a decrease in 8-
OHdG adduct formation was observed in corn oil fed rats (Fig. 7).   
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Aberrant crypt formation.  All rats were injected twice with the colon specific 
carcinogen AOM and consumed experimental diets for 7 wk after AOM injection.  
To measure the protective effect of each experimental diet against colon 
carcinogenesis, aberrant crypt formations were quantified.  Aberrant crypt 
FIGURE 7 Oxidative DNA damage was measured by quantification of 8-OHdG 
adduct stain intensity in AOM injected rats fed a corn oil or fish oil based diet with 
and without quercetin supplementation. Quercetin supplementation had more of a 
protective effect when added with corn oil; when added to fish oil there was no 
decrease in DNA damage. Data are means ± SEM from 20 crypts for n=10 rats/diet 
for no quercetin supplementation and n=9 rats/diet for quercetin supplementation.  
Bars not sharing a letter differ (p=0.0428). 
   a   a 
    b   a,b 
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formation was significantly suppressed in fish oil rats as compared to corn oil 
animals (Fig. 8).  Quercetin however, had no effect on aberrant crypt formation. 
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Discussion 
 
 One of the most critical control processes in cancer prevention and treatment has 
been shown to be apoptosis induction (95).  If ROS generation exceeds cellular 
antioxidant capacity oxidative stress will result.  Elevated ROS levels can then 
initiate and/or modulate signaling cascades, one of which is apoptosis induction. 
We have previously shown that the dietary combination of fish oil and pectin has 
the ability to alter the oxidative status of rat colonocytes via ROS generation and 
modulation of antioxidant enzyme activity, thus creating an environment 
permissive for apoptosis (9,16).  Addition of antioxidants to this pro-oxidant 
environment may alter cellular redox balance and compromise the ROS-mediated 
mechanism whereby fish oil and pectin diets initiate apoptosis.  Therefore, the 
FIGURE 8 AOM injected rats fed a corn oil diet had significantly 
higher aberrant crypt numbers as compared to fish oil fed rats.  
Quercetin supplementation had no effect on aberrant crypt formation. 
Data are means ± SEM for n=10 rats/diet.  Bars not sharing a letter 
differ (p<0.0001). 
    b 
   a 
   a 
    b 
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intent of this study was to evaluate whether an antioxidant, quercetin, could alter 
the cellular redox balance of rat colonocytes and compromise the mechanism 
whereby the dietary combination of fish oil and pectin initiates apoptosis.  We 
hypothesized that the addition of quercetin to a fish oil and pectin enriched diet 
would decrease apoptosis through its effects on endogenous antioxidant enzyme 
activities (SOD, CAT, and GPx), which would change redox balance 
(GSH/GSSG), and increase the level of oxidative DNA damage.  The modulation 
of these aforementioned cellular systems should therefore negate the 
chemoprotective effect of fish oil and pectin enriched diets leading to an increase 
in AC numbers during the promotion stage of colon carcinogenesis. 
Data from this experiment showed a significant increase in apoptosis in 
both corn oil and fish oil fed rats (pectin as the fiber source) with the addition of 
quercetin to the diet. We have also demonstrated an increase in apoptosis in rats 
consuming diets containing corn oil and quercetin when cellulose was the fiber 
source (96).  Quercetin has been shown in vitro to enhance TNF-related apoptosis-
inducing ligand (TRAIL) apoptosis through Akt dephosphorylation in human 
prostate cancer cell lines (97).  In the in vivo study conducted by Warren et al., no 
change in total Akt or PI3 kinase levels were observed (96).  Another mechanism 
of apoptosis induction is through ROS-mediated pathways involving the 
mitochondria.  A recent study observed that the level of ROS and malondialdehyde 
was increased in quercetin treated hepatoma cells (23).  These results correlated 
well with quercetin induced cytotoxic effects in isolated rat liver nuclei (98) and 
comparable results in human leukemic HL-60 cells (99).  These studies strongly 
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suggest that quercetin has pro-oxidant activity in vitro and thus, may have 
contributed to apoptosis induction through an ROS-mediated pathway in the 
colonocytes from rats consuming quercetin.   
We previously showed in normal rat colonocytes that as the levels of ROS 
rose, the apoptotic index rose exponentially (p=0.005) (9).  This previous study 
involved analyzing enzyme activity levels in normal rat colonocytes fed fish oil or 
corn oil and used pectin or cellulose as the fiber source for 4 wk.  Fish oil and 
pectin fed rats had lower antioxidant enzyme activity levels of SOD and CAT and 
comparable levels of GPx activity as compared to corn oil and cellulose fed rats 
(9). Similar experiments in rat colonocytes observed also that dietary fish oil 
lowers antioxidant enzyme activities of SOD, CAT, and GPx (100).  SOD, CAT, 
and GPx enzymes are critical determinants of cellular antioxidant capacity and 
ROS elimination.  These enzymes act sequentially to quench ROS, therefore the 
balance of the activities of these enzymes are just as important as the activity of 
each enzyme alone.  SOD coverts superoxide anion (O2.-) into H2O2, which is then 
converted to H2O and O2 by GPx or CAT.  Although GPx and CAT both 
decompose H2O2, the amount of H2O2  produced and whether H2O2 is found in the 
cytosol or mitochondria, dictates the relative contribution of these two enzymes 
toward H2O2 removal (43,101).  The current experiment used AOM injected rats, 
and we saw consistent numerical reduction in SOD activity in the fish oil fed rats, 
which when the main effect of lipid was analyzed fish oil fed rats had a 
significantly lower SOD activity level than corn oil fed rats.  Quercetin did not 
diminish this effect. Fish oil fed rats exhibited a greater CAT activity as compared 
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to corn oil fed rats, however upon addition of quercetin, this difference was 
eliminated. Because a decrease in CAT activity has been found in a variety of 
animal tumors (102), the significant reduction in CAT activity for the fish oil fed 
rats with quercetin may negatively affect the chemprotective effects of this diet if 
the study were continued to the tumor stage, which is possible as suggested by the 
tendency (N. S.) for AC to increase in fish oil fed rats with quercetin in the diet.  
The SOD/CAT ratio was higher for corn oil fed rats as compared to fish oil fed 
rats.  In fact we also observed a tendency for AC to decrease in corn oil fed rats 
supplemented with quercetin (Fig. 8).  Corn oil fed rats with and without quercetin 
supplementation exhibited a significantly higher level of GPx activity as compared 
to fish oil fed rats.  The differences in antioxidant enzyme activity levels observed 
in this experiment compared to previous studies may be due to the fact that the 
current experiment measured antioxidant enzyme activity of  rat colonocytes 
excised 7 wk post 2nd AOM exposure whereas the previous experiments were in 
normal rats (9) and an ulcerative colitis rat model (100), and the ages of the rats 
where also different than those in the current study. 
Dietary fish oil and pectin did protect against AC formation in this study.  
We still observed that protection with the addition of quercetin to the diet. The 
ability of the fish oil and pectin enriched diet to enhance apoptosis appears to be 
due in part to the modulation of the redox environment (9,16).  This study 
examined the redox environment using GSH/GSSG, a frequently used indicator of 
oxidative status.  Several studies suggest that a shift in the cellular environment 
towards a more oxidative state is the major initiator for apoptosis rather than the 
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cellular oxidative status at a particular timepoint (68-71).  In this investigation we 
demonstrate that the combination of dietary fish oil and pectin tends to promote a 
more reduced cellular environment (elevated GSH/GSSG) as compared to the 
combination of dietary corn oil and pectin.  This reduced environment produced by 
fish oil and pectin suggests that upon exposure to a chemical carcinogen, fish oil 
and pectin enriched colonocytes are better able to endure an oxidative shift 
sufficient to trigger apoptosis, but not so severe as to enhance oxidative DNA 
damage (9,18). The elevated GSSG levels for corn oil fed rats supplemented with 
quercetin further suggests that quercetin may indeed affect recycling of GSSG 
back to GSH.  This correlates with a previous study which observed that quercetin 
can change the activity of glutathione reductase, the enzyme responsible for 
reducing GSSG back to GSH (103).   
Although dietary fish oil and pectin alter the antioxidant enzyme activities 
of SOD, CAT, and GPx as compared to corn oil and pectin, and produced a more 
reduced environment as reflected in the GSH/GSSG ratios, there was not a 
reduction in 8-OHdG DNA adducts.  However, upon addition of quercetin to the 
diet, corn oil fed rats did have a significant decrease in 8-OHdG adduct formation.  
Despite the significant reduction in oxidative DNA damage to the corn oil fed rats 
supplemented with quercetin and dramatic increase in apoptosis, fish oil fed rats 
with and without quercetin supplementation displayed a significantly lower level 
of AC.  However, there was a tendency for AC to be reduced in the corn oil fed 
rats with quercetin supplementation as compared to those without 
supplementation.   These finding suggest that fish oil and quercetin are utilizing 
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distinctly different mechanism to induce apoptosis, and the mechanism utilized by 
fish oil seems to more chemoprotective than the mechanism utilized by quercetin.  
In summary the combination of dietary fish oil and pectin have been shown 
to enhance colonocyte apoptosis by modulation of the cellular redox environment.  
In this study dietary fish oil and pectin decreased the enzyme activities of SOD 
and GPx, while increasing CAT activity and GSH/GSSG in the rat colonocyte of 
AOM injected rats.  Although fish oil and pectin did not reduce oxidative DNA 
damage as compared to corn oil and pectin, fish oil did significantly reduce AC.  
Upon the addition of quercetin to the fish oil pectin diet antioxidant enzyme 
activities of SOD and GPx were comparable to the non-quercetin enzyme 
activities.  Although CAT activity was significantly higher in fish oil fed rats than 
corn oil fed rats without quercetin in the diet, the addition of quercetin to the diets 
diminished the effect of higher CAT observed in fish oil fed rats.  Quercetin also 
had a tendency to create a shift to a more oxidized environment in corn oil fed rats 
as analyzed by GSH/GSSG, yet we observed a significant increase in apoptosis 
and a slight tendency to lower AC with this dietary combination. This study also 
demonstrates that the mechanisms used by chemopreventive agents are critical to 
whether combinations of chemopreventatives are synergistic or antagonistic.  
Further investigations should evaluate the exact in vivo mechanism of dietary fish 
oil and pectin as well as quercetin, and whether quercetin is more beneficial to an 
n-6 as compared to an n-3 enriched diet in the initiation, promotion, and 
progression stages of colon cancer. 
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CHAPTER IV 
SUMMARY AND CONCLUSIONS 
 
Summary  
 
The oxidative environment of the colonocyte plays a critical role in the 
susceptibility of the colon to rid itself of malignant cells via apoptosis.  The 
cellular redox environment is determined by the balance of ROS generation and 
antioxidant defenses. Therefore modulation of this environment through dietary 
measures is indeed a beneficial strategy in colon cancer chemoprevention.  
Colon cancer is one of the most preventable cancers by dietary 
intervention, and fat and fiber are two of the most widely investigated dietary 
components in colon cancer prevention.  Studies have shown that pectin in 
combination with fish oil has a synergistic protective effect on multiple stages of 
colon cancer.  This effect is largely due to the up-regulation of apoptosis (7,15).  
Evidence suggests that this up-regulation of apoptosis by these dietary components 
is through modulation of the redox cellular environment resulting in a pro-oxidant 
environment such that colonocytes are more receptive to pro-apoptotic signals, 
especially those generated by ROS.  
Other studies have shown that the proportion of the population that has the 
lowest intake of fruits and vegetables has twice the incidence of cancer of 
epithelial origin (3,20,21).  More studies show that people whose diets were rich in 
fruits and vegetables had a lower incidence of diabetes, stroke, heart disease, 
dementia, and certain types of cancer.  These diseases are all associated with free 
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radical damage (87).  Since fruits and vegetables are rich sources of antioxidants 
and thus have the power to quench free radicals by donating electrons, scientists 
assumed that taking antioxidants as supplements or fortifying foods with 
antioxidants should decrease oxidative damage and diminish disease.  Randomized 
clinical trials using antioxidants to prevent several diseases have shown that 
antioxidant supplementation can increase cancer incidence and mortality 
(84,85,89).  Dietary quercetin is postulated to contribute to the chemoprotective 
activities of fruits and vegetables through its antioxidant properties 
(22,23,25,26,28-31,90).  The purpose of our study was to determine if the addition 
of quercetin to an experimental diet of fish oil and pectin would decrease apoptosis 
because of modifications in cellular redox status, thus increasing aberrant crypt 
formation. 
In this investigation, we show that apoptosis is enhanced by dietary 
quercetin in AOM exposed rat colonocytes.  This increase in apoptosis was seen in 
both the corn oil and fish oil fed rats.  The greatest differences in enzyme activities 
were seen in rats without quercetin in the diet.  With addition of quercetin to the 
diet the differences observed stayed the same for SOD and diminished for CAT.  
In the case of GPx we observed a numerical increase in activity for corn oil fed 
rats, causing a significant difference in activity between corn oil and fish oil fed 
rats with quercetin supplementation.  GSH was not affected by diet; yet, GSSG 
was elevated in corn oil fed rats compared to fish oil fed rats with quercetin.  
Quercetin also had a tendency to create a more oxidized environment in corn oil 
fed rats as analyzed by GSH/GSSG, yet we observed a significant increase in 
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apoptosis and a tendency to lower AC with this dietary combination.  There was 
no difference in overall levels of 8-OHdG adducts in fish oil vs corn oil fed rats.  
However, upon the addition of Q, a decrease in 8-OHdG adduct levels was 
observed in corn oil rats.   
 
Conclusions 
 Despite increasing apoptosis, and lowering 8-OHdG adduct levels in corn oil fed 
rats, quercetin had little effect on AC formation. These data suggest that quercetin 
may have created a greater oxidant load than corn oil alone, which shifted redox 
balance to a more oxidized state as compared to corn oil only animals. The small 
decrease in AC caused by quercetin in the corn oil fed rats may have resulted from 
the accumulation of GSSG making the colonocyte more susceptible to apoptosis 
induction and thus lowering AC formation.  The small increase in AC caused by 
quercetin in the fish oil fed rats may have resulted from the lower CAT activity 
caused by this dietary combination. The distinct effects of the diets suggest that the 
corn oil and quercetin and fish oil and quercetin combinations are functioning 
through different mechanisms, yet the mechanism used by fish oil appears to be 
more protective in the promotion stage of colon carcinogenesis as observed in this 
study and in agreement with Chang et al. (7). This may be in part due to intrinsic 
vs extrinsic apoptosis induction.  Kolar et al. (8) demonstrated that the 
combination of fish oil and pectin exhibit an enhanced ability to induce apoptosis 
and protect against colorectal cancer in part by recruiting a Ca 2+-mediated 
intrinsic mitochondrial pathway in addition to a nonmitochondrial, Fas-mediated, 
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extrinsic pathway.  This study and the current study demonstrate that an 
understanding of the mechanisms used by putative chemopreventive agents is 
critical in determining whether combinations of chemopreventatives will be 
synergistic or antagonistic.   
Because quercetin had a tendency to lower AC and 8-OHdG adducts in 
corn oil fed rats and increase AC in fish oil fed rats, the long-term consequences of 
supplementing antioxidants to a diet thought to exert its anticancer effect through a 
pro-oxidant mechanism are unknown and deserve further study.  Further 
investigations should also evaluate the exact in vivo mechanism of dietary fish oil 
and pectin as well as quercetin, and whether quercetin is more beneficial to an n-6 
as compared to an n-3 enriched diet in the initiation, promotion, and progression 
stages of colon cancer. 
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APPENDIX A 
EXPERIMENTAL PROTOCOLS 
Kill Day Set-up & Checklist 
General 
• Tape bench papers on lab benches and line with extra bench papers; 
replace bench papers as necessary. 
• Put up instruction/reminder sheets and Rat Kill List at every station. 
• Put out gloves of all sizes, boxes of Kim wipes, sufficient napkins, and 
sharpies at each station. 
• Make sure liver Rnase-free utensils and supplies are properly “Zapped” the 
day before kill. 
• Label timers, ACF tub covers, homogenization tubes and pestles 
• Tape 2 - 3 biohazard bags on benches where needed 
• Make solutions, ensure plenty of reserves; chill those that require chilling. 
 RNase-free & regular 1X PBS 
 4% PFA  
 50% & 70% EtOH 
 Heparin Soln. 
• Complete rat’s 48-hr diet intakes 
• Move homogenization buffer from freezer to fridge 
• Put up rat kill lists and instruction sheets 
• Inform Aleta to prepare cages, covers and a cart for rats to be moved up to 
2nd floor 
• Tapes & Dispenser 
• Assemble rat transport cages 
 
Kill Station 
• Check CO2 tank, chamber, weights, cover cloth 
• Black trash bags for rat bodies 
• PBS in squirt bottle-RNAse Free 
• Surgical tools 
1. Straight scissors (black handle) 
2. Bent large scissors 
3. Forceps-(1) bent, (1) straight 
4. Small blunt tip scissors 
• Extra bench papers 
• Weigh dishes, 1 big, 1 medium, 2 small labeled with rat # 
• Extra weigh dishes all sizes 
• Rat packs 
• Gauze – lots 
• Ice bucket for PFA cubes 
• 1 ml pipette with tips 
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• Instruction sheet 
• Liquid Nitrogen Container 
• Sharps Container 
• Sharpie 
• Gloves 
 
 
ACF Station 
• Big weigh dishes labeled with rat # (for holding colon) 
• PBS in squirt bottle (1) 
• 600mL glass beaker (1) covered w/foil 
• Ice bucket (to hold PBS beaker) (1) 
• 10cc syringe attached with RNase-free round-tip needle (4)  
• Scapels & blades (4) 
• Forceps (1 straight, 1 bent) 
• Small blunt-tip scissors (1) 
• Medium weigh boats for colon 
• Labeled Whatman filter papers (in ziplock bag) 
• ACF tupperwares and glass plates (2) 
• Boat with 70% ethanol 
• 70% EtOH 
• “ART XLP 200”, P200 pipette (1) 
• Biohazard bag 
• Record sheet for any observations 
 
 
Cassetting Station 
• Ice tubs for holding small specimen cups (1) 
• Labeled timers with rat # (8) 
• Labeled big specimen cup with lid for holding cassettes fixed in 70% EtOH 
(1) 
• Labeled cassettes with sponges (2/rat) 
• Forceps (1 straight, 1 bent) 
• Small scissors (1) 
• 1X PBS in squirt bottle 
• Labeled rat #, date and fixation small specimen cups with lids (wrap ones) 
for holding cassettes fixed in 4% PFA (8) 
• Large weigh boats labeled with rat # 
• Cold 4% PFA 
• 70% EtOH 
• Igloo coolers for holding ice (2) 
• Record sheet for PFA fixation EtOH changes 
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Mucosal Scrapping and Homogenization Stations 
• Ice buckets for storing homogenization buffer and eppetubes 
• Homogenization buffer 
• Denaturation Buffer 
• 2ml RNAse free eppitube /rat 
• Ice box for holding glass 
• Piggyback racks for holding eppitubes  
• Square ice box for holding square glass plate 
• Microscope slides 
• Curved forcep (1) 
• Water in squirt bottle (from bottled sterile water) 
• 1X PBS in squirt bottle 
• “ART XLP 200”, “ART 1000E”, and “10 Reach” pipette tips 
• P1000 pipette (2), P200 pipette (1), and P10 pipette (1) 
• Small specimen cups for rinsing (2) 
• 2-mL homogenization tubes and pestles (labeled and in ziplock bags) 2/rat 
• Pre-weighed tubes for GSH/GSSH 
• Homogenization instruction sheet 
• Balance 
• Data sheet 
 
 
Protein Isolation Station 
• Centrifuge machine 
• Timer labeled (4) 
• 1cc Luer-Lok syringe with 27G 1¼  needle (8+) 
• Sharps container 
• Labeled 0.65mL  
• 2 mL eppetubes for protein (2) (1 white to centrifuge, 1 yellow to transfer 
supernatant) 
• Ice chest to hold eppitubes (2) 
• Piggyback rack 
• P200 and P1000 pipettes and pipette tips 
• Calculator 
• Instruction sheet 
• Remarks record sheet and sharpie 
• Gloves 
 
Liver Station 
• 3 ice buckets 
• Zapped glass plate (4) 
• 1.8 ml tubes (2/rat) 
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• Labeled RNA later bottle – 5 ml (1/rat) 
• Chopping tools (4) 
• Zapped scissors 
• NaCl and heparin solution (300 ml/ rat) 
• Beaker 250 ml (covered w/foil) 
• 10 ml syringe(2) and needles (1/rat) 
• Cryobags for extra liver (1/rat) 
• Kimwipes 
• Gloves 
• Catch Tub for liver perfusion 
• Tub of Soapy Water 
• Large liquid nitrogen container 
• Spatulas –Spoon shaped (2), Straight (2) 
• Pen, Sharpie 
• Ziplock bag 
• Instruction Sheet 
 
Blood Station 
• 1 ice bucket next to centrifuge 
• 0.6 and 0.3 ml heparin tube 
• 1 ml cryotube 
• Container for liquid N2 
• Rotator and ice in cold room 
• Centrifuge at 4 °C 
• Balance 
• Syringe 2 ml/needle 
• Pipette heparinated 
• 3 Marma tubes 
• 1 marma – Ac tube 
• Balancing tubes for centrifuge 
• Recording Sheet 
• Sharpie Pen 
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Morning of Kill 
1. Take protease inhibitor and protein buffer (previously aliquoted) out of 
freezer to thaw.  
2. Scoop lots of ice and fill necessary tubs, boxes, and mug; store the 
remaining in ice igloos. 
3. Take out heparin solution keep on ice  
4. Remove denaturation solution from fridge; keep in ice. 
5. Turn on both centrifuges at appropriate temp. 
6. Add protease inhibitor to buffer and keep in ice. 
7. Prepare and move rats from basement to kill station; keep food in cages. 
8. Assemble specimen cups for cassetting – put in tub filled with ice, fill with 
ice-cold 4% PFA, store in ice chest. 
9. Fill ACF tubs and EtOH fixation specimen cups with 70% EtOH. 
 
 
After Kill 
1. Store samples in appropriate place 
2. Clean up 
3. Autoclave biohazard trash and bring to dumpster 
4. Bring rat bodies to freezer in basement diet mixing room 
5. Wash tools and glassware; put to dry in oven 
6. Solution changes 
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ABERRANT CRYPT FOCI ENUMERATION PROTOCOL 
(Cindy Warren, 2001. Modifications by Kim Paulhill, 8/2006) 
Supplies: 
  Methelyne blue in clear specimen cup 
  PBS in clear specimen cup 
  70% Ethanol in clear specimen cup 
  Rubber gloves 
  Long stem cotton swabs 
  Labeled tissue samples in clear specimen cups 
  Clear grid (with ½ cm squares) 
  ACF score sheets 
  Flash Drive 
  Paper towels 
  Clip board 
Procedure:   
1. Place all supplies in small cooler with waffle lab bench paper in 
the bottom of cooler in case of spillage. 
2. In the microscope room, turn on the four switches and prepare to 
use the microscope (computer, scope, TV screen, grey box).    
3. Stain the tissue by dipping in the methylene blue for 10-45 
seconds.  If too dark dip it back into 70% ethanol.   
4. Place on plastic grid taped onto microscope stage, beneath lens, 
10 X magnifications.  Take care not to touch the lens.   
5. Note rat ID number, length of colon, date, etc. on the score sheet.   
6. Starting on the distal end (this end doesn’t have tissue 
architecture with ridges).  Go slowly through each box, 
examining the tissue.   
7. Note any ACF, both position and multiplicity. 
• Normal crypts are oval or round and a lighter blue 
stain.   
• ACF are darker and have swirl-like appearance.   
• Many of the ACF have increased size, thicker 
epithelial lining, and darker staining luminal 
openings.   
• Compare the ACF to the surrounding tissue.   
• Hyperproliferative crypts are not as distorted as the 
ACF. 
• ACF have a larger white, distorted zone in the 
luminal opening.   
• Peyer’s patches are lymphatic tissue; look like big 
cloudy spots  
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8.  Make sure that tissue does not dry out—using cotton swap,     
moisten tissue periodically with PBS.  It should remain shiny. 
9.  This procedure is totally subjective.  Determine individual 
standards for scoring ACF and remain consistent with each 
tissue.   
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Date   Sample 
______  ___________________ 
  ___________________ 
 
Apoptosis – ApopTag 
Modified by Lisa Sanders for NSBRI initiation study 
Used by Kim Paulhill for Quercetin Project 
Original Protocol:  ApopTag Kit with modifications by Wen-Chi Chang & April 
Carney 
02/2006 
 
Note:  To be performed on 4%PFA fixed tissue. 
 
***Put 200 ml PBS for Prot. K in 37° C oven and begin bleach rinse. 
 
___1.  Deparaffinize and rehydrate tissue: 
 ___Xylene, 3X, 5 min 
        let xylene just dry, circle sections w/ PAP pen, dry 1 min 
 ___100% EtOH, 2X, 5 min 
 ___95% EtOH, 1X, 3 min 
 ___70% EtOH, 1X, 3 min 
 ___PBS, 1X, 5 min 
(Get Equilibration Buffer and Reaction Buffer out of freezer-put on ice) 
 
___2.  Pretreat tissue – 3 min, in 37° 
 Proteinase K (10 μg/ml PBS)  = 0.1 ml Proteinase K (Ambion # 2546) in 
200 ml PBS. 
 
___3.  Wash in dH2O, 2x, 2 min 
 
___4.  Quench Endogenous Peroxidase: 0.3% H2O2 in 100% Methanol: 
3.0 ml 30% H2O2 in 297 ml 100% Methanol or 2.0 ml in 198 ml(add fresh 
H2O2 immediately before quenching).  30 min, RT 
 
___5.  Wash in dH2O, 2x, 5 min 
  
___6.  Wash all slides in PBS 5 min. 
 
___7.  Gently tap off PBS and carefully blot around sections.  (Do this step and 
following step one slide at a time to avoid drying out sections.) 
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___8.  Apply EQUILIBRATION BUFFER to all sections:  incubate in humidified 
chamber for 15 sec to 1 hr @ RT. 
 (# of slides X 150 μl) (9 slides X 150μl = 1.35 ml) 
  
___9.  Tap off equilibration buffer and immediately apply REACTION BUFFER 
(- controls) or working strength TdT Enzyme with dilution ratio 1/10 
(enzyme /reaction buffer).  (Get TdT directly from freezer & keep on ice) 
 
Apply only reaction buffer to  – control sections: 
___(# sections) X 40μl 
 
For normal sample sections (# sections X 40μl): 
___1080 μl  reaction buffer (for 9 slides) 
___36 μl TdT enzyme (for 9 slides) 
 
Incubate in a humidified chamber at 37°C, 1 hr 
(Prepare Stop/Wash so it can warm to RT.) 
 
___12. Put slides in coplin jar with Working Strength Stop/Wash Buffer (1ml + 34 
ml dH2O).  Agitate for 15 sec; incubate 10 min, RT. 
Take aliquot of ANTI-DIGOXIGENIN PEROXIDASE (# slides X 125 
μl) and allow to warm to room temperature (9 slides x 125μl = 1.125ml) 
 
___14.  Wash slides in PBS, 3X, 1min 
 
___15.  Blot dry the slides quickly (do one slide at a time) and apply ANTI-
DIGOXIGENIN PEROXIDASE to all sections; incubate 30 min. in 
humidity chamber @ RT. 
 
___16.  Wash in PBS 4X, 2min 
Prepare DAB peroxidase (1:50, substrate:dilution buffer) (#slides x 
150μl) and warm to room temperature.  Protect from light. (9 slides X 
150μl = 1350μl = 27μl substrate:1323μl dilution buffer) 
 
___17.  Blot dry the slides quickly (do one slide at a time) and stain sections with 
DAB until light brown color shows up  (< 1 min). 
 
___18.  Wash in dH2O, 3X, 1 min  
 Leave in 4th  for 5 min 
 
___19. Counterstain w/ Methyl Green (reusable): 
 Dip quickly into Methyl green 
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 Rinse in dH2O 5X; dip 1x in the 1st 2 changes and briefly agitate 
Dip 10 x in 3rd & leave ~ 30 sec. 
Leave in the last 2 for 1 min w/o agitation 
 
___20.Dehydrate: ALL FRESH 
__70% EtOH, 1X, 1 min 
__95% EtOH, 1X, 1 min 
__100% EtOH, 1X, 1 min 
__Xylene: 3X, 2 min  (dip 10 times/ea) 
 
___21. Wet mount w/ Permount (80:20, Permount:Xylene) – leave overnight to 
dry 
 
 
reagent  company          catalog # 
Apotag Kit:  Chemicon    S7101 
Proteinase K  Ambion   2546 
PBS   Life Technologies  21600-069  
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Tissue:     Name:    
 Date: 
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Tissue:     Name:    
 Date: 
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BUFFER SELECTION – PROTEIN HOMOGENIZATION 
 
 
3 rats were killed to practice antioxidant assay in colon mucosa. 2 different kinds 
of buffers were used to homogenize the protein.  Particulate buffer and Dr. Wu’s 
modified buffer. 
The buffer was modified by Jairam, Laurie and Dr. Turner, so the samples can be 
used for Western blot assays.  Dr. Wu’s modified buffer seemed to offer better 
results for antioxidant enzyme quantification than the particulate homogenization 
buffer.  Apparently the protein recovery is also higher with Dr. Wu’s modified 
buffer.  However, this buffer was used for the actual experiment.  10 mL of buffer 
were prepared for each killing day (8 rats).  
 
 
 
DR. WU’S HOMOGENIZATION BUFFER 
 
 
1. Preparation of Stock solutions 
 
      Stock 1.  50mM K2HPO4:  Dissolve 4.35g of K2HPO4 in 500ml of deionized 
H2O 
 
Stock 2.  50mM KH2PO4:  Dissolve 3.4g of KH2PO4 in 500ml of deionized 
H2O (use 1L bottle) 
 
Stock 3.  Prepare 50mM Potassium Phosphate buffer (pH 7.2) 
Add 50mM K2HPO4 (stock 1) to 50mM KH2PO4 (stock 2) until pH is 7.2 
 
Stock 4.  Prepare 250mM Sucrose/1mM EDTA solution by dissolving 42.8g 
of sucrose and 186mg of disodium EDTA in 500ml of potassium phosphate buffer 
(stock 3).  pH again to 7.2 (use KOH or HCl) 
 
 
 
2.  Preparation of homogenization buffer (adapted from Dr. Wu’s assay for 
enzyme extraction).  250mM sucrose/1mM EDTA/1mM DTT in 50mM 
potassium phosphate buffer:   
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5ml   250mM sucrose/1mM EDTA solution (stock 4) 
200μl    protease inhibitor cocktail 
5μl    Triton X-100 (0.1%) 
5μl    1M DTT solution (made fresh) 
0.3858 mg DTT in 2.5mL Phosphate Buffer 
 
DR. WU’S MODIFIED HOMOGENIZATION BUFFER 
(Modification suggested by Jairam, Laurie and Dr. Turner) 
 
 
250 mM sucrose/1mM EDTA/1mM DTT in 50 mM potassium phosphate buffer.  
Modification consists of final concentration of 0.1% triton rather than 0.0001% 
and use of sodium orthovanadate.  
 
 
PREPARATION OF DR. WU’S MODIFIED HOMOGENIZATION BUFFER 
1.  Preparation of Stock solutions 
 
      Stock 1.  50mM K2HPO4:  Dissolve 4.35g of K2HPO4 in 500ml of deionized 
H2O 
 
Stock 2.  50mM KH2PO4:  Dissolve 3.4g of KH2PO4 in 500ml of deionized 
H2O (use 1L bottle) 
 
Stock 3.  Prepare 50mM Potassium Phosphate buffer (pH 7.2) 
Add 50mM K2HPO4 (stock 1) to 50mM KH2PO4 (stock 2) until pH is 7.2 
 
Stock 4.  Prepare 250mM Sucrose/1mM EDTA solution by dissolving 42.8g 
of sucrose and 186mg of disodium EDTA in 500ml of potassium phosphate buffer 
(stock 3).  pH again to 7.2 (use KOH or HCl) 
 
2.  Preparation of homogenization buffer 
 
 
 
 
64
 
 
Stock 
Solutions 
10 mL 
Buffer 
50 mL 
Buffer 
Company cat. # Storage 
250 mM 
Sucrose/1mM 
EDTA solution 
(stock 4) 
9.4 mL 47 mL K2HPO4 & 
KH2PO4 (Sigma) 
Sucrose (Sigma 
S7903) 
EDTA (disodium) 
Sigma ED4SS 
Frozen 
Triton X-100 
10% 
100 μl 500 μl Peroxidase free 
Calbiochem 
648464 
Frozen 
1M DTT  
 
10 μl 50 μl Sigma D9779 Made fresh  
10 mM 
Sodium 
orthovanadate 
100 μl 500 μl Sigma S6508 Frozen 
Protease 
inhibitor 
400 μl 2 mL Sigma P8340 Add just 
before use 
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Coomassie Protein Assay 
 
Equipment: 
Microtiter plate reader (A595) 
 
Reagents: 
Coomassie Plus Protein Assay Kit Pierce 23236 
 contains Coomassie Blue stain 
     BSA standards (2mg/ml) 
 
Procedure: 
1. Prepare BSA standards: 
2μg/μl (in kit) 
500μl of 2μg/μl + 500μl ddH2O = 1μg/μl 
125μl of 2μg/μl + 1000μl ddH2O = 0.25μg/μl 
(this is sufficient for only one set of standards) 
2. Prepare microcentrifuge tubes of standards and samples in triplicate.  
(Add Coomassie to all tubes last.) 
 
Standards: 
μg 
protein 
0.25μg
/μl 
BSA 
1μg/
μl 
BSA 
2μg/
μl 
BSA 
Water Homog. 
Buffer 
Coomassie 
Reagent 
0 0μl - - 497.5μl 2.5μl 500μl 
1 4μl - - 493.5μl   
2 - 2μl - 495.5μl   
4 - 4μl - 493.5μl   
10 - 10μl - 487.5μl   
20 - - 10μl 487.5μl   
   
 Samples: 
Amt. of 
sample 
Water Coomassie 
Reagent 
2.5μl 497.5μl 500μl 
 
3. Incubate samples in Coomassie at RT for 10 minutes. 
4. Transfer 300μl of each tube to the appropriate well on a microtiter plate. 
5. Read absorbance (A595) on microtiter plate reader. 
(Absorbances for standards generally range from 0.3 to 1.0.) 
6. Plot standard curve (absorbance vs. μg protein).  Most plate readers will do 
this for you. 
7. Use readout of “unknowns” to determine protein concentration of samples. 
 
 
 
 
66
 
 
Catalase  Assay Kit 
Catalogue # 219265 
www.calbiochem.com 
 
Materials Provided: 
10X Assay Buffer 
10X Sample Buffer 
Formaldehyde Standard Kit 
Catalase Control 
Potassium Hydroxide 
Methanol 
Hydrogen Peroxide 
Purpald 
Potassium Periodate 
96 Well Plate and Plate Sealer 
 
Materials Required but not Provided: 
Plate Reader (540 nm filter) 
Adjustable Pipettor 
Repeat Pipettor 
Distilled or HPLC-grade water 
 
Reagent Preparation 
1. 10X Assay Buffer 
a. Dilute 2ml 10X Assay Buffer with 18ml of HPLC-grade water 
b. This is 1X Assay Buffer to be used in Assay 
c. Store at 4°C-Stable for at least 2 months 
2. 10X Sample Buffer 
a. Dilute 5 ml of 10X Sample Buffer with 45 ml HPLC-grade water 
b. This is 1X Sample Buffer should be used to dilute standards, 
controls, samples prior to assaying 
c. Store at 4°C-Stable for at least 2 months 
3. Catalase (Control) 
a. Add 2 ml of 1X Sample Buffer and Vortex well 
b. Take 100µl of reconstituted enzyme and dilute with 1.9ml of 1X 
Sample Buffer 
c. Diluted enzyme is stable for 30 min 
d. Reconstituted CAT is stable for one month at -20°C 
4. Potassium Hydroxide 
a. Place vial on ice, add 4ml cold HPLC-grade water and vortex 
b. Store at 4°C stable for at least 3 months 
5. Hydrogen peroxide 
a. Dilute 40µl Hydrogen Peroxide with 9.96 ml HPLC-grade water 
b. Dilute Hydrogen Peroxide solution is stable for 2h. 
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Detailed Protocol 
1) Prepare Formaldehyde Standards 
a)     Dilute 10µl of Formaldehyde Standard with 9.99 ml 1X Sample Buffer 
b)    Add the amount of Formaldehyde Standard and 1X Sample Buffer to 
each tube as laid out below 
 
 
Tube Formaldehyde 
Stock (µl) 
Sample 
Buffer 
(µl) 
Final 
Concentration 
(µM 
formaldehyde) 
A 0 1000 0 
B 10 990 5 
C 30 970 15 
D 60 940 30 
E 90 910 45 
F 120 880 60 
G 150 850 75 
2) Formaldehyde Standard Wells 
a) Add 100µl 1X Assay Buffer 
b) 30µl Methanol  
c) 20µl Formaldehyde Standards (tubes A-G) 
3) Positive Control 
a) Add 100µl 1X Assay Buffer 
b) Add 30µl Methanol  
c) Add 20µl diluted Catalase Control 
 
4)  Sample Wells 
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a) Add 100µl 1X Assay Buffer 
b) Add 30µl Methanol  
c) Add 20µl sample 
 
5)  Initiate the reactions by adding 20 µl dilute Hydrogen Peroxide to all wells 
 
a) Note time Started 
 
6) Cover Plate with plate sealer and incubate on shaker for 20 min at room temp. 
 
7) Add 30µl Potassium Hydroxide to each well to terminate reaction 
 
8) Add 30µl of Purpald to each well 
 
9) Cover plate with plate sealer and incubate for 10 min at room temp. on shaker 
 
10) Add 10µl Potassium Periodate to each well.  Cover with plate sealer and 
incubate at room temp. on shaker for 5 min. 
 
11)  Read absorbance at 540nm 
 
Calculating Results of Catalase Assay 
 
1) Calculate avg. absorbance for each standard or sample 
 
2) Subtract avg. absorbance of standard A from itself and all other standards 
and samples. 
 
3) Plot corrected absorbance of standards as a function of final formaldehyde 
concentration 
 
4) Calculate the formaldehyde concentration of the samples using the 
equation obtained from the linear regression of the standard curve 
substituting corrected absorbance values for each sample 
 
a. Formaldehyde (µM)=(Sample absorbance - y-intercept/ slope) 
x(0.17 ml/0.02 ml) 
 
5) Calculate Catalase Activity of the Sample using the following equation 
a. One unit is defined as the amount of enzyme that will cause the 
formation of 1.0 nmol formaldehyde per min at 25°C 
b. CAT Activity = (µM of sample/20 min)x Sample dilution = 
nmol/min/ml 
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Superoxide Dismutase Assay 
Caymen Chemicals 
Catalog #706002 
Range of Kit is 0.025-0.25 units/ml SOD 
 
Contents of Kit 
1. Assay Buffer (10X) 
2. Sample Buffer (10X) 
3. Radical Detector 
4. SOD (standard) 
5. Xanthine Oxidase 
6. 96 Well Plate 
7. Plate Cover 
Additional Items Required 
1. Potassium Cyanide 
2. Plate Reader with 450nm filter 
3. Adjustable pipettors and a repeat pipettor 
4. Glass distilled water or HPLC-grade water 
 
Pre-Assay Preparation 
1. Assay Buffer-(10X)-(Vial #1) 
a. Dilute 3ml of Assay Buffer with 27ml of HPLC-grade water 
Assay buffer is used to dilute Radical Detector  
Store at 4°C-Stable for 2 Months 
2. Sample Buffer-(10X)-(Vial #2) 
a. Dilute 2ml of Sample Buffer concentrate with 18 ml of HPLC-
grade water 
i. Final Sample Buffer should be used to prepare the SOD 
standards and Dilute xanthine oxidase and SOD samples 
prior to assaying 
Store at 4°C-Stable for 2 Months 
3. Radical Detector-(Vial #3) 
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a. Transfer 50:l of tetrazolium salt to another vial and dilute with 
19.95 ml of diluted Assay Buffer 
b. Cover with Foil 
c. Stable for 2 hours 
4. SOD standard-(Vial #4) 
a. Bovine Erythrocyte SOD(Cu/Zn) 
i. Ready to use as supplied 
ii. Store thawed enzyme on ice 
5. Xanthine Oxidase (Vial #5) 
a. Thaw one vial 
b. Transfer 50:l of enzyme to another vial 
c. Dilute with 1.95 ml of diluted Sample Buffer 
d. Store on ice-stable for 1 hour 
i. Do not refreeze thawed enzyme 
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Performing the Assay 
The Assay Temp is 25°C and Absorbance at 450 nm 
All reagents except samples and xanthine oxidase must be equilibrated to room 
temperature before beginning the assay. 
1. Preparation of SOD standards 
a. Dilute 20:l of SOD standard (Vial #4) with 1.98 ml of  diluted 
Sample Buffer to each tube as described below: 
Table 1 
Tube SOD stock(:l) Sample Buffer (:l) Final SOD Activity 
(U/ml) 
A 0 1,000 0 
B 20 980 0.025 
C 40 960 0.05 
D 80 920 0.1 
E 120 880 0.15 
F 160 840 0.2 
G 200 800 0.25 
 
2. SOD Standard Wells-Add 200:l of diluted Radical Detector and 10:l of 
Standard(tubes A-G) in designated wells on plate  
3. Sample Wells- Add 200:l of diluted Radical Detector and 10:l  of Sample 
or : 
a. 190:l of diluted Radical Detector 
b. 10:l of inhibitor (potassium cyanide) 
c. 10:l of sample 
4. Initiate reaction by adding 20:l of diluted xanthine oxidase to all wells 
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a. Note Precise time started 
b. Add as quickly as possible 
5. Shake Plate for 5 sec. to mix and cover with plate cover 
6. Incubate on a shaker for 20 min at room temp 
7. Read absorbance at 450nm using a plate reader 
Calculating Results 
1. Calculate average absorbance of each standard and sample 
2. Divide Standard A’s absorbance by itself and divide standard A’s 
absorbance by all the other standards and samples absorbances to yield the 
linearized rate (LR) 
a. (i.e. LR for Std A= Abs Std A/ Abs Std. A;  LR for Std B=Abs Std A/ 
Abs Std B) 
3. Plot the linearized SOD standard rate (LR) as a function of final SOD 
Activity (U/ml) from Table 1  
4. Calculate the SOD activity of the samples using the equation obtained 
from the linear regression of the standard curve substituting the linearized 
rate (LR) for each sample.   
a. One unit is defined as the amount of enzyme needed to exhibit 50% 
dismutation of superoxide radical. 
b. SOD(U/ml)= [(Sample LR-y-intercept/slope)x (0.23ml/0.01ml)] x 
sample dilution 
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Glutathione Peroxidase Assay Kit 
Catalog No. 703102 
 
Glutathione peroxidase (GPx) catalyzes the reduction of hydroperoxides, 
including hydrogen peroxide, by reduced glutathione and functions to protect the 
cell from oxidative damage. 
R-O-O-H + 2GSH R-O-H + GSSG + H2O 
 
GSSG + NADPH 2GSH + NADP+ 
 
 
 
Pre-Assay Preparation 
Preparation of reagents: 
1. Assay Buffer (10X)-(vial #1) 
a. Dilute 2 ml of Assay Buffer concentrate with 18 ml of HPLC-grade 
water 
b. Stare at 4ºC – stable for at least 2 months 
2. Sample Buffer (10X)- (vial#2) 
a. Dilute 2 ml of Sample Buffer concentrate with 18 ml of HPLC-
grade water 
b. Store at 4ºC – stable for at least 1 months 
3. Glutathione Peroxidase (Control)-(vial #3) 
a. Transfer 10 µl of enzyme and dilute with 490 µl of diluted Sample 
Buffer and keep on ice. 
b. Stable for 4 hours on ice. 
4. Co-Substrate Mixture- (vial # 4) 
a. Add 2ml of HPLC-grade water to each vial needed ( each vial is 
enough for 40 wells) 
b. Reconstituted Reagent should be kept at 25°C while assaying and 
then stored at 4°C 
c. Stable for 2 days at 4°C 
5. Cumene Hydroperoxide-(vial #5) 
a. Reagent is ready to use as supplied 
b. Store at -20°C 
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Performing the Assay 
 
• The final Volume of the assay is 190µl in all the wells 
• The assay temperature is 25°C 
• Use the Assay Buffer dilute in the assay 
• Monitor the decrease in absorbance at 340 nm using a plate reader 
 
1. Background or Non-enzymatic Wells- Add 
a. 120µl of Assay Buffer  
b. 50µl of co-substrate mixture to three wells 
2. Positive Control Wells (bovine erythrocyte GPx)- Add 
a. 100µl of Assay buffer,  
b. 50µl of co-substrate mixture, 
c. 20µl of diluted GPx (control) to three wells. 
3. Sample Wells- Add 
a. 100 µl of Assay Buffer,  
b. 50µl of co-substrate mixture,  
c. 20µl of sample to each well 
4. Initiate reaction by adding 20µl of cumene hydroperoxide 
5. Shake plate for a few seconds to mix 
6. Read absorbance once every minute at 340 nm using plate reader to obtain 
at least 5 time points. 
 
Calculating the Results 
 
Determination of the Reaction Rate: 
1. Determine the change in absorbance per minute by: 
a. Plotting the values as a function of time to obtain  the slope (rate) of 
the linear portion of the curve -OR- 
b. Select two points on the linear portion of the curve and determine 
the change in absorbance during that time using the following 
equation: 
i. ΔA340/min=A340(Time 2) – A340(Time 1)/ (Time 2(min.)-
Time 1 (min.)) 
2. Determine the rate of ΔA340/min. for the background or non-enzymatic 
wells and subtract this rate from that of the sample wells. 
3. Use the following formula to calculate the GPx activity. 
a. One unit is defined as the amount of enzyme that will cause the 
oxidation of 1.0 nmol of NADPH to NADP+ per minute at 25ºC.  
GPx Activity= ((ΔA340/min)/ 0.00373µM-1)x (0.19ml/0.02ml )x sample 
dilution = nmol/mim/ml 
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Immunohistochemistry of 8-hydroxy-2’-deoxyguanosine 
Note:  For 70%EtOH fixed tissue. 
Day 1 
 
___1. Deparaffinize slides and rehydrate tissue: 
 ___3 x 5 min Xylene 
 ___Let slide just dry, circle sections with PAP pen, dry 1 min 
 ___2 x 2 min 100 % ETOH 
 ___2 x 2 min 95 % ETOH 
 ___1 x 2 min 70 % ETOH 
 ___1 x 5 min H2O 
 
___2. Wash in TBS for 2 min x 2.  Gently tap off TBS and blot around sections.  
(Do this step and following step one slide at a time to avoid drying out 
sections.) 
 (Prepare RNase dilution.) 
 
___3. Treat sections with RNase (100 μg/ml Tris buffer) for 1 h at 37 °C in 
humidity chamber. 
(Tris buffer recipe and RNase prep listed on separate sheet.) 
 
___4. Wash in TBS for 2 min x 3. 
 
___7. Denature DNA by placing slides in 4 N HCl for 7 min at RT. 
(HCl recipe on separate page.) 
 
___8. Neutralize with 50 mM Tris base for 5 min at RT. 
(Tris base recipe on separate page.) 
 
___9. Wash in TBS for 5 min x 2.  Gently tap off TBS and blot around sections.  
(Do this step and following step one slide at a time to avoid drying out 
sections.) 
 (Prepare 10% serum.) 
 
___10. Incubate sections with 10% rabbit serum (Jackson #011-000-120) in 
TBS 1 h at RT in humidity chamber.  
 (Prepare primary Ab dilution.) 
 
___11. Incubate sections with primary Ab (1:20 in TBS w/ 1% rabbit serum 
(50mM Tris)) (Oxis #24325) at 4 °C in humidity chamber overnight.  
(Recipe for TBS with 50mM Tris on separate page.) 
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Day 2 
 
___12. Wash in TBS for 5 min x 3.  Gently tap off TBS and blot around sections.  
(Do this step and following step one slide at a time to avoid drying out 
sections.) 
 (Prepare secondary ab dilution.) 
 
___13. Incubate sections with biotinylated rabbit anti-mouse (1:800 in TBS w/ 
1% rabbit serum (remember already diluted 1:1 in glycerol)) (Jackson 
#315-065-045) 45 min at RT in humidity chamber.  
  
___14. Wash in TBS for 5 min x 3. 
 
___15. Apply 3% H2O2 (Sigma #H-1009) in methanol for 30 min to quench 
endogenous peroxidase. 
 (Add 1ml H2O2 for every 10 ml of methanol.  Add H2O2 immediately 
before quenching.) 
 (Prepare ABC-HRP and let stand for 30 min.) 
 
___16. Wash in TBS for 5 min x 3.  Gently tap off TBS and blot around sections.  
(Do this step and following step one slide at a time to avoid drying out 
sections.) 
 
___17. Incubate with ABC-HRP kit (Vector #PK-6100) for 1 h at RT in 
humidity chamber.  
1) 5 ml 1X TBS 
2) Add 2 drops of reagent A and mix well 
3) Add 2 drops of reagent B and mix well 
 
___18. Wash in TBS for 5 min x 3.  Gently tap off TBS and blot around sections.  
(Do this step and following step one slide at a time to avoid drying out 
sections.) 
(Prepare DAB and water rinse.) 
 
___19. Apply DAB (Vector #SK-4100) stain for 1 min (or until brown stain 
shows up).  Tap off DAB, rinse briefly with ddH2O and place in ddH2O.  
Finish one slide before moving to next slide. 
1) 5 ml dH2O. 
2) 2 drops of buffer, mix. 
3) 4 drops of DAB, mix. 
4) 2 drops of H2O2, mix. 
 
___20. Wash in ddH2O for 1 min x 2. 
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___21. Dehydrate slides: 
 1 x 1 min 70 % ETOH.      
 1 x 1 min 95 % ETOH. 
 1 x 1 min 100 % ETOH. 
 1 x 2 min Xylene. 
 
___22. Mount cover glass with Permount (Fisher #SP15-500). 
 (Permount diluted - 20% xylene, 80% permount.) 
 
 
 
Recipes for 8-oxodG 
 
TBS (20mM Tris, 0.9% NaCl, pH 7.5) (Sigma) – all washes and dilutions except 
primary ab 
As received: 10X Concentrate 
Dilution: 1X with ddH2O 
 
Adjust pH to 7.5 with HCl.  Prepare as needed. 
 
 
TBS (50mM Tris, 0.9% NaCl, pH 7.5) – for primary ab dilution only 
121.1g/mol x 0.05mol/L = 6.055 g/L Tris base (Sigma #T-1503) 
0.9% NaCl x 1000ml = 9g NaCl (Sigma) 
    1 L ddH2O 
 
Adjust pH to 7.5 with HCl.  Prepare as needed. 
 
 
Tris Buffer (10mM Tris, 1mM EDTA, 0.4M NaCl, pH 7.5) – for RNase dilution 
121.1g/mol x 0.01mol/L = 1.211 g/L Tris base (Sigma #T-1503) 
380.2g/mol x 0.001mol/L = 0.3802 g/L (Sigma # ED4SS) 
58.44g/mol x 0.4mol/L = 23.38 g/L (Sigma #BP358-1) 
    1L ddH2O 
 
Adjust pH to 7.5 with HCl.  Prepare as needed. 
 
 
Tris base (50mM) 
121.1g/mol x 0.05mol/L = 6.055g/L 
    1L ddH2O 
 
Do not pH.  Prepare as needed. 
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RNase (Ambion #2272) 
As received: 1ml [1mg/ml] 
Dilution: 100ug/ml Tris buffer 
 
100ul stock + 900ul Tris buffer = 1ml of 100ug/ml 
 
Remove aliquot on day of assay.  Add Tris buffer to appropriate dilution. 
 
 
4N HCl 
As received: 30M solution 9 (EM Science #HX0603-3) 
Dilution: 4M solution 
 
Normality = molarity x number of H+ released by acid 
4N HCl = 4M HCl 
 
4M/30M = 0.13 
130ml of 30M HCl 
870ml of ddH2O 
 
Prepare as needed. 
 
 
Rabbit Serum (Jackson #011-000-120) 
As received:  Freeze dried 
Reconstitution: Add 5ml ddH2O (100% serum) – good for 6 weeks at 4° 
Dilution:  10% serum – good for 1 day 
 
1ml 100% serum 
9ml TBS 
 
Remove aliquot on day of assay.  Add TBS to appropriate dilution. 
 
Primary Antibody (Oxis # 24325) 
As received:  Freeze dried 20 ug vial  100 ug vial 
Reconstitution: 100ug/ml 0.2 ml ddH2O  1ml ddH2O --good 
1month at 4° 
Dilution:  5-10ug/ml with TBS (50mM Tris) 
 
Remove aliquot on day of assay.  Add TBS to appropriate dilution. 
 
 
Secondary Antibody (Rabbit anti-mouse:  Jackson #315-065-045) 
As received:  Freeze dried 
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Reconstitution: Add 1ml ddH2O – good for 6 weeks at 4° 
   Add equal portion of glycerol (1ml) – store in -20° 
Dilution:  1:600 in TBS (1:300 if in glycerol) 
 
2ul antibody / 4ul antibody (in glycerol)  
1200ul TBS 
Remove aliquot on day of assay.  Add TBS to appropriate dilution. 
 
 
3% H2O2 in methanol 
30% H2O2  (Sigma H-1009) 
100% Methanol 
 
Add 1ml of 30% H2O2 to every 10ml of MeOH for 3% H2O2. 
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HPLC Analysis of GSH, GSSG, Cysteine and Cystine 
Modified By Kim Paulhill 7/2007 
The principle: the reduced form of glutathione (GSH) an the oxidized form of 
glutathione (GSSG), as well as cystine and cysteine, are derivatized with dansyl 
chloride in the presence of iodoacetic acid and KOH/teraborate (pH 9.0) to yield 
fluorescence derivatives.  The derivatives are separated by HPLC and quantified 
using fluorescence detection. 
 
1. Chemicals: 
a. Sodium Heparin       
b. Bathophenanthroline Disulfonate Sodium Salt (BPDS)  
c. Iodoacetic Acid       
d. Dansyl Chloride       
e. L-serine        
f. GSH         
g. GSSG 
h. Cystine 
i. Cysteine               
j. Sodium Acetate Trihydrate      
k. Boric Acid 
l. Sodium Tetra Borate 
 
2. Preparation of Solvents and Reagents: 
a. 100 mM Boric Acid:  Dissolve 3.1g boric acid in 500ml HPLC 
H20 
b. 100 mM Sodium Tetraborate:  Dissolve 19.1g sodium tetraborate in 
500ml HPLC H20 
 
i. Solution A (Presevation Solution):   
1. Dissolve 1.05g L-Serine 
2. 50 mg sodium Heparin 
3. 100 mg BPDS 
4. 200 mg  iodoacetic acid 
5. in 80 ml of 100mM boric acid 
6. 20 ml of 100mM sodium tetraborate 
7. Solution is stable at -80°C for 6 months 
8. (Note: Heparin to inhibit coagulation, serine⋅borate to inhibit 
degradation of GSH by (-glutamyltranspeptidase, 
bathophenanthroline disulfonate to inhibit GSH oxidation, and 
iodoacetic acid to alkylate GSH). 
 
ii. Solution B (10% perchloric acid, w/v; 0.2 M boric acid): 
1. Dissolve 6.2 g boric acid in 300 ml HPLC water 
2. Add 71 ml of 70% perchloric acid 
3. quiesce to 500ml with HPLC water  
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iii. Derivatization solutions: 
1. KOH/tetrahydroborate solution (pH 9.0): 
a. Add 5.6 g KOH  
b. to a plastic bottle containing 50g K2B4O7⋅4H20 
and 100ml HPLC water 
c. Mix- (Stable indefinitely at 25°C) 
2. Iodoacetic Acid: 
a. Dissolve 14.8 mg iodoacetic acid in 2ml of 
HPLC water 
b. Made fresh the day of derivatization 
3. Dansyl chloride: 
a. Dissolve 200mg dansyl chloride in 10ml of 
HPLC acetone 
b. Made fresh the day of derivatization 
 
3. GSH, GSSG, Cystine, and Cysteine standards: 
a. 2 mM GSH, GSSG, Cys, and Cystine: 
i. Dissolve 6.16 mg GSH 
ii. 12.2 mg GSSG 
iii. 2.44 mg cysteine 
iv. 4.8 mg cystine 
v. In 5ml of Sol A + 5ml of Solution B 
b. 500 nmol/ml GSH, GSSG, Cys, and Cystine: 
i. Mix 50µl of 2 mM standards 
ii. With 75µl of Sol A+ 75µl of Sol B 
c. 50 nmol/ml GSH, GSSG, Cys, and Cystine: 
i. Mix 50µl of 2 mM standards 
ii. With 975µl of Sol A+ 975µl of Sol B 
d. Blank (0 nmol/ml): 
i.  Mix  200µl of Sol A+ 200µl of Sol B 
 
4. Extraction of Glutathione from Tissue 
a. Tissue Homgenization for small sample size;(~ 5 to 10 mg tissue) 
i. Homogenize the tissue in 0.1 ml Sol A+ 0.1 ml Sol B 
ii. Rinse Homogenizer with 0.1 ml Sol A + 0.1 ml Sol B 
iii. Combine Homogenates 
iv. Centrifuge all tubes at 10,000 g for 1 min. 
v. Use supernatant for derivatization 
5. Derivatization 
a. Add to 1.5 ml microcentrifuge tube (use amber tubes): 
i. 150µl of standards (0, 50, 500 nmol/ml) or samples 
ii. 30µl of Iodoacetic acid solution 
iii. 100µl of KOH/tetraborate sol. (pH ~9) 
iv. Vortex and wait 20 min 
b. Add 150µl of dansyl chloride solution to each tube 
i. Vortex 
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ii. Keep all tubes in dark at room temp. for 16 h. 
c. Add 250µl of HPLC-grade chloroform to each tube(to extract the 
free dansyl-Cl) 
i. Vortex and centrifuge at 10,000 g for 1 min 
ii. (The dansyl derivatives are stable in the dark at 0-4°C for 
12 months) 
iii. Use upper aqueous layer for HPLC analysis 
d. Add 100µl of sample (or standard) derivatives to a micro-insert 
tube in a brown vial 
i. Vortex 
ii. Injection volume: 25µl 
6. HPLC Analysis 
a. HPLC solvents: 
i. Solvent A (Acetic Acid Buffer, pH 4.6) 
1. 640 ml Methanol + 200 ml Acetate stock solution 
+125 ml Glacial acetic acid + 50 ml HPLC water 
2. (Acetate Stock solution: Dissolve 272 g sodium 
acetate trihydrate in 122 ml HPLC water and 378 ml 
glacial acetic acid) 
ii. Solvent B (80% Methanol; v/v): 
1. 800 ml HPLC Methanol + 200 ml HPLC water 
b. HPLC Column: 3-Aminopropyl column (5 um; 4.6 x 250 mm) 
i. Custom LC, Houston, TX: Tel 800-537-9339) 
 
 
 
c. HPLC solvent gradient: 
     Solvent                                         Time(min) 
                                                                          0     10     30     33     33.1     38 
                                      Solvent A (%)             20   20     80     80     20        20 
                                      Solvent B (%)             80   80     20     20     80        80 
   Flow rate: 1.0 ml/min 
    
   Fluorescence detection (Waters 2475 Multi λ Fluorescence 
Detector): 
0.0 to 7.5 min: 590 nm excitation; 610 nm emission 
7.5 to 38 min:  335 nm excitation; 610 nm emission 
    
   Gain: 10 (0 to 32.2 min): 100 (32.2 to 38 min).   
(For liver samples) 
   Gain: 100 (0 to 32.2 min): 1000 (32.2 to 38 min).  
  (For other samples) 
    
   Attenuation: 1 
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   Retention time: Cys-16.7 min, Cysteine-20.1 min, GSH- 29.4 min,  
  GSSG- 3.8 Min 
 
d. References:(104) 
 
 
  
 
Chemicals & supplies needed: 
Name Supplier & Catalog # 
Sodium Heparin Sigma H4784 
Bathophenanthroline disulfonate sodium salt (BPDS) Sigma B1375 
Iodoacetic acid Sigma I2512 
Dansyl chloride Sigma 39220 (Fluka) 
L-serine Sigma S4500 
GSH standard Sigma G6529 
GSSG standard Sigma G6654 
Cystiene Standard Sigma C-7352 
Cystine Standard Sigma C122009 
Sodium acetate trihydrate Sigma 236500 
Boric acid Sigma B0394 
Sodium tetraborate Sigma 221732 
70% Perchloric acid Fisher A469 
HPLC grade water Fisher W7 
Potassium hydroxide (KOH) Sigma P5958 
Potassium tetraborate tetrahydrate Sigma P5754 
Acetone Fisher A949 
Chloroform Sigma 650498 
Glacial acetic acid Bio/Bio 
Methanol (HPLC grade) Fisher A452 
3-aminopropyl column CEL Associates #132-204
Ph# 800-537-9339 
Pearland, TX 
 
Other supplies & equipment needed: 
balance tweezers 
1.5 ml eppi tubes (2/sample) ice & ice chest 
vortex mini vortexer 
mini centrifuge HPLC glass vials with springs, inserts & lids 
pipet and tips calculator 
HPLC insert tubes Waters   Wat72030 
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HPLC Recording Sheet 
 
Sample 
Description 
Cryo/Sample 
Weight  
(mg) 
Cryo-
Only     
Weight 
(mg) 
Sample 
Weight 
(mg) 
Sol 
A/Sol 
B 
Added 
Vol 
(µl) 
Total 
Vol. 
(µl) 
20 
min 
Incub. 
(In 
Dark) 
Start 
Time 
16 hr 
End  
Time 
16 hr 
Storage 
Date 
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APPENDIX B 
 
TABLES OF RESULTS 
 
 
     TABLE 3 
 
Average Food Intake (g)1 
 
Diet                 Non-Quercetin                         Quercetin 
                      Corn Oil       Fish Oil                    Corn Oil        Fish Oil             p-value 
 
Day 18-20    16.84 ± 0.33a,b    16.60 ± 0.33a              17.19 ± 0.33a    17.66 ± 0.33b           0.0385 
 
Day 56-58    20.02 ± 0.60      19.72 ± 0.60           19.39 ± 0.60    19.49 ± 0.60           NS 
 
Day 67-69    19.94 ± 0.38      20.04 ± 0.38           20.12 ± 0.38    18.90 ± 0.38           NS 
 
      
 
 
 
 
 
TABLE 4 
 
Average Weight Gain Day (g)1 
 
Diet                 Non-Quercetin                         Quercetin 
                      Corn Oil       Fish Oil                    Corn Oil        Fish Oil             p-value 
 
Day 18-20    6.66 ± 0.46        6.62 ± 0.46               6.30 ± 0.46      6.39 ± 0.46              NS  
 
Day 56-58    2.84 ± 0.57        3.01 ± 0.57                3.32 ± 0.57     3.07 ± 0.57           NS 
 
Day 67-69    1.99 ± 0.45        1.89 ± 0.45                2.23 ± 0.45     2.46 ± 0.45           NS 
 
      
 
 
 
 
 
 
 
 
 
 
1Values represent LS Means ± S.E.M. of average food intake for n= 10 
rats/ diet, means without a common letter differ. NS=Not Significant 
1Values represent LS Means ± S.E.M. of average weight gain for n= 10 
rats/ diet.  NS= Not significant. 
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TABLE 5 
 
High Multiplicity ACF (4+) 1 
 
 
Diet                                   Corn Oil                        Fish Oil 
 
(-) Quercetin                 0.60 ± 1.26a                   0.00 ± 0.00b 
 
(+) Quercetin                0.20 ± 0.42a                    0.00 ± 0.00b 
 
 
 
 
 
 
TABLE 6 
 
Average Mitochondrial SOD (Mn-SOD) Enzyme Activity (U/mg protein)1 
 
Diet                                   Corn Oil                        Fish Oil 
 
(-) Quercetin                  8.14 ± 1.17                     7.88 ± 1.17 
 
(+) Quercetin                 9.28± 1.17                      8.29 ± 1.17 
 
 
 
 
1Values represent LS Means ± S.E.M. of average Mn-SOD enzyme 
activity for n= 10 rats/ diet. 
1Values represent Means ± Std D of average high multiplicity ACF with 4 
or more aberrant crypts in foci for n= 10 rats/ diet, means without a 
common letter differ, p= 0.0184
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